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ABSTRACT 
Background and purpose 
Disability in people living with human immunodeficiency virus (HIV) has become a 
major health problem especially in HIV endemic countries like South Africa. In this 
study we determined the validity and reliability of the first specific disability 
assessment instrument for people living with HIV, the HIV Disability Questionnaire 
(HDQ). 
Methodology 
Adults living with HIV were recruited from hospital clinics and AIDS service 
organizations in South Africa. A demographic questionnaire and HDQ paired with 
two reference measures were administered. To assess construct validity, factor 
analysis, convergent and divergent validity and level of disability against known 
group variables were determined. Cronbach’s alpha was established to determine 
reliability of the HDQ. 
Results 
Of the 498 participants, the majority were females (68.27%) and were taking 
antiretroviral therapy (100%). Majority of the participants were black (95.18%) and 
have a median age of 41 years. Confirmatory factor analyses indicated goodness 
of fit similar to that previously shown for the HDQ, with the hypotheses for 
convergent and divergent validity and known group variables being accepted. 
Internal consistency was good with Cronbach’s alpha values above 0.7 for all 
domains on the HDQ. 
Conclusions 
The HDQ demonstrates a variable degree of construct validity and internal 
consistency when administered to adults living with HIV in South Africa.  
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DEFINITION OF TERMS    
Disability 
A disability is a function or condition judged to be significantly impaired relative to 
the usual standard of a group or individual. The term is used to refer to individual 
functioning, including sensory impairment, physical impairment, intellectual 
impairment, mental illness, cognitive impairment, and various types of chronic 
disease. Disability as defined by the  International Classification of Functioning, 
Disability and Health (ICF) “umbrella term for these impairments, as well as 
activity limitations and participation restrictions” (WHO, 2001).  
Activity Limitation 
The execution of a task or action by an individual is defined as activity and 
difficulty at the individual level is considered an activity limitation(WHO, 2001). 
Participation restriction 
Involvement in a life situation is defined as participation and difficulty at the 
societal level is considered as participation restriction(WHO, 2001). 
Uncertainty 
Uncertainty associated with disabilities has been defined as the perception that 
one lacks the ability to predict, explain, or establish meaning of illness-related 
circumstances (Brashers, 2001; Mishel, 1988). 
Episodic 
Episodic disabilities are long-term conditions that are characterized by periods of 
good health alternated by periods of disability or illness. These periods may vary 
in length, severity and predictability from one person to another (O’Brien et al., 
2008). 
Validity 
Validity is the degree to which a research study/instrument measures what it 
intends to measure (Gravetter & Forzano, 2009). 
Construct validity 
“Is the degree to which a test measures what it claims to be measuring and refers 
to the degree to which inferences can legitimately be made from the 
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operationalisations to the theoretical constructs on which those operationalisations 
were based." (Gravetter & Forzano, 2009). 
Factor Analysis 
This is a type of statistical method used to show the variability among observed, 
correlated variables in terms of a potentially lower number of unobserved variables 
called factors (Kielhofner, 2006). 
Confirmatory Factor Analysis 
Structural equation modelling that focuses mainly with measurement models 
which is the relationship between latent variables and observed measures (Brown, 
2015). 
Convergent Validity 
This can be defined as a parameter which measures the degree to which two 
measures of constructs that theoretically should be related are in fact related 
(Kielhofner, 2006). 
Divergent Validity 
This is also known as discriminant validity and it’s a parameter which measures 
the degree to which constructs that should have no relationship do, in fact, not 
have any relationship (Kielhofner, 2006). 
Reliability 
Reliability is the consistency of results when the experiment is replicated under the 
same conditions (Kielhofner, 2006). 
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ABBREVIATIONS 
AIDS   Acquired immune deficiency syndrome 
ART    Antiretroviral therapy or treatment 
CES-D   Centre for Epidemiologic Studies Depression Scale 
COPE   Coping with Problems Experienced 
DALY   Disability adjusted life years 
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HIV   Human immunodeficiency virus 
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HRQoL  Health related quality of life  
ICF    International Classification of Functioning, Disability and 
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MOS-SSS   Medical Outcomes Study Social Support Survey 
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UNAIDS  Joint United Nations Programme on HIV and AIDS 
WHO   World Health Organisation 
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CHAPTER 1:  INTRODUCTION  
1.1 BACKGROUND AND NEED 
Since the advent of antiretroviral treatment or therapy (ART), people living with 
human immunodeficiency virus (PLWHIV) have experienced extended survival 
rates, but this has been accompanied by physical, psychological and socio-cultural 
challenges (Nixon, Hanass-Hancock, Whiteside, Barnett, 2011). Studies have 
stated that these challenges occur in the early stage and continue through the 
stages of the disease (Banks, Zuurmond, Ferrand, & Kuper, 2015; Hannass-
Hancock, Myezwa, & Carpenter, 2015; Rusch, Nixon, Schilder, Braitstein, Chan, & 
Hogg, 2004; Deeks, Lewin, & Havlir, 2013). 
The incidence and prevalence rate of HIV infection is a significant problem in sub-
Saharan Africa, as 23.5 million people are living with HIV in this region (UNAIDS, 
2012). Only Botswana, Swaziland and Lesotho have a higher prevalence rate of 
HIV infection than South Africa (SA) (WHO, 2010). Furthermore, SA is reported to 
have the highest number of PLWHIV (UNAIDS, 2012). 
Literature indicates that the challenges PLWHIV face may be due to the health 
related consequences of the condition and may be as a result of the disease itself, 
side effects of the medications or concurrent health conditions (Rusch, et al., 
2004). The challenges can vary from emotional disturbance related to dealing with 
the diagnosis to the social effect of the diagnosis including isolation and stigma. 
Physical and/or emotional discomfort is also associated with the progression of the 
disease, all of which can interfere with day-to-day functioning (Ezeamama, 
Woolfork, Guwatudde, Bagenda, Manabe, Fawzi, et al., 2016). 
O’Brien, Bayoumi, Strike, Young, & Davis. (2008) report that these health related 
challenges in PLWHIV can be referred to as “disability”. This disability includes 
challenges resulting in impairments, activity limitations and participation 
restrictions in the individual’s everyday life based on the International 
Classification of Functioning, Disability and Health (ICF) (World Health 
Organization, 2001; O’Brien, Bayoumi, Strike, Young, & Davis. 2008; O’Brien, 
Solomon, Bergin, O’Dea, Stratford  Iku, et al., 2015): This was confirmed by a 
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study on PLWHIV, carried out by Rusch, et al. in British Columbia in 2004. They 
reported high levels of activity limitations and participation restrictions were 
experienced by between 80.6% and 93.2% of PLWHIV respectively (Rusch et al., 
2004). However, this study was somewhat limited due to the homogenous nature 
of its participants. 
 It was shown in  South Africa that just under half the participants of a cohort of 
1042 adults taking ART, in a study by Hanass-Hancock et al. (2015), presented 
with one or more activity limitation when assessed by the World Health 
Organisation Disability Assessment Scale-2 (WHODAS 2.0). Of these participants, 
35% had limitations that were considered as the onset of disability (Hanass-
Hancock, et al., 2015). It is important that assessments that include other aspects 
of disability are validated on this population to indicate the extent of disability 
present in PLWHIV as these findings have implications for rehabilitation of these 
disabilities. It was estimated  in June 2015, that 6.19 million people in South Africa 
were living with HIV and if 35% of this population present with limitations then 
rehabilitation services may be needed for 2.17 million (Stats SA, 2015). It is, 
therefore, important to have valid assessment instruments of disability in this 
population so that the extent and level of disability can be determined for the 
planning of adequate rehabilitation services. 
This will also allow rehabilitation professionals including occupational therapists, to 
understand and address disability related to activity limitations, and participation 
restrictions in PLWHIV. The need to define and establish the role of rehabilitation 
in general and occupational therapy in particular in addressing these aspects in 
HIV care was emphasised by Hanass-Hancock et al. (2015). In order to achieve 
this, assessment of disability which specifically considers PLWHIV and that has 
been validated in a developing country like South Africa is needed. 
O’Brien et al. (2008) contributed to understanding the specific disability 
experienced by PLWHIV when they developed the Episodic Framework on which 
they based assessment of disability in this population. This framework considered 
the fluctuating health related challenges faced by those living with HIV and 
included the component of uncertainty about the future as part of disability 
(O’Brien et al., 2008). Four types of “uncertainty” specific to living with HIV after 
starting antiretroviral therapy have been described. These include (a) feelings of 
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hope as a result of improved immunological functioning; (b) anxiety as a result of 
role changes between ill-health and health (c) interpersonal relations, including 
stigmatisation; and, (d) reassessment of life (Brashers, Neidig, Cardillo, Dobbs, 
Russell, & Haas, 1999). 
Based on this understanding of disability in PLWHIV O’Brien et al. developed an 
assessment specifically for individuals living with HIV, the HIV Disability 
Questionnaire (HDQ) in 2014. The HDQ is a 70 item questionnaire, with 6 
domains which assess the disabilities in PLWHIV on 3 scales namely, the 
presence, severity and episodic scales (O’Brien, Solomon, & Bayoumi, 2014). The 
HDQ was developed from the episodic disability framework and it conceptualizes 
disability into 4 categories which include impairments, activity limitations, 
participation restrictions and uncertainty (O’Brien, Solomon & Bayoumi, 2014).  
This instrument’s validity and reliability have been tested in Canada and Ireland 
based on known group variables related to disability in PLWHIV such as age and 
concurrent health conditions. Convergences to activity limitations and participation 
restrictions assessment instruments and divergence from quality of life 
assessment instruments were also established. An individual’s quality of life, is 
affected  by HIV and may deteriorate as the disease progresses (Burgoyne & 
Saunders., 2001; Ezeamama et al., 2016). As O’Brien Solomon, Bergin, O’Dea, 
Stratford, Iku, & Bayoumi. (2015) point out quality of life assessment instruments 
consider constructs outside the scope of disability, however, they include the 
meaning of social relationships and “personal goals, values, and expectations” 
(O’Brien et al., 2015)  
The convergent validity, divergent validity and confirmatory factor analysis of the 
HDQ is limited to samples in developed countries, thus making the generalisability 
of these findings to other populations difficult (O’Brien, et al., 2015). It is unknown 
if the HDQ is valid in identifying disability in PLWHIV in developed countries where 
the incidence of HIV is greater and the disease is more prevalent in females. 
Current co-morbid conditions are also more likely to be related to Tuberculosis 
(TB) and diarrhoea as well as access to medical care and medication which may 
be limited (Shisana, Rehle, Simbayi, Zuma, Jooste, Zungu, et a. 2014; Tun, Okal, 
Schenk, Esantsi, Mutale, Kyeremaa, et al. 2016; Sarfo, Sarfo, Norman, Phillips, 
Bedu-Addo & Chadwick, 2014). 
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1.2. STATEMENT OF PROBLEM  
Studies on disability related activity limitations and participation restrictions in 
PLWHIV and more importantly in occupational therapy are limited (Hanass-
Hancock, et al., 2015). Studies on disability in terms of impairments, activity 
limitations and participation restrictions in PLWHIV in South Africa have used 
generic disability assessments and at present, there is only one assessment of 
disability specifically developed for use with PLWHIV receiving ART, the HIV 
Disability Questionnaire (HDQ). The HDQ has only been validated in first world 
developed countries like Canada and Ireland (O’Brien, et al., 2015) although the 
highest incidence of HIV is in sub-Saharan Africa. (UNAIDS, 2012). There is a 
need to validate this instrument in developing countries and in the African context 
so that reliable data on disability related activity limitations and participation 
restrictions of PLWHIV can inform the development of appropriate services to 
address the health and well-being of these individuals. 
1.3. PURPOSE OF THE STUDY  
The purpose of the study was therefore to confirm the validity and reliability of the 
HDQ for a sample of PLWHIV accessing ART in Johannesburg Metro South 
Africa. The study is focused on a selected sample in South Africa which is a 
developing country. According to Stats SA, (2015), the population of PLWHIV who 
are accessing available ART in South Africa is the highest in the world 
necessitating the need to have a valid assessment tool to conceptualize the 
disabilities experienced by this population.  
1.4 AIMS AND OBJECTIVES OF THE STUDY 
The aim of this study was to determine the selected aspects of validity and 
reliability of the HIV Disability Questionnaire (HDQ) on a sample of PLWHIV in 
Johannesburg.  
Objectives  
1. To confirm the domains represents a single construct of the HDQ on the 
sample of persons living with HIV in Johannesburg Metro, to confirm if HDQ 
measures what it is supposed to measure. 
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2. To determine the convergent validity of the HDQ by testing hypotheses 
based on the convergence with the World Health Organisation Disability 
Assessment Scale (WHODAS-2) on a sample of persons with HIV living in 
Johannesburg 
3. To determine the divergent validity of the HDQ by testing hypotheses based 
on the divergence with the Medical Outcomes Study Social Support Survey 
(MOS-SSS) on a sample of persons with HIV living in Johannesburg 
4. To confirm the known group validity by comparing the level of disability 
assessed by the HDQ scores to known demographic and medical variables. 
5. To determine the reliability of the HDQ in terms of internal consistency in 
the sample of PLWHIV IN Johannesburg. 
1.5 THE HYPOTHESES FOR CONSTRUCT VALIDITY 
1.5.1 Convergent and Divergent Validity Hypotheses 
In the absence of any gold reference measures for assessing disability and quality 
of live in PLWHIV reference assessment instruments developed for use with 
people living with chronic health conditions were chosen. These assessment 
instruments, the WHODAS 2 and MOS-SSS have been validated on large 
samples (Üstün 2010, Gjesfjeld, Greeno, & Kim, 2007; Sherbourne & Stewart, 
1991). 
1.5.1.1 Convergent validity 
It was hypothesized that the total HDQ presence, severity and episodic scores of 
all the domain scores would have a positive high to moderate correlation with the 
total score of the WHODAS 2.0 since the two reference assessment instruments 
measure the same construct which are the three domains (impairments, activity 
limitations, and participation restrictions) of disabilities.  
It was hypothesised that the:  
 The impairment domains on the HDQ Domain 1: physical symptoms and 
Domain 2: cognitive symptoms have a positive high to moderate correlation 
with mobility and cognitive domains on the WHODAS 2.0 respectively.  
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 The domains on the HDQ representing participation restrictions Domain 4:  
uncertainty, Domain 5: difficulties with day to day activities and Domain 6: 
challenges with social participation scores have a positive high to moderate 
correlation with participation restrictions domain on the WHODAS 2.0. 
Domain 5: difficulties with day to day activities correlate moderately with 
activity 1 and 2 domains on the WHODAS 2. 
 The HDQ Domain 6: challenges with social participation scores have a 
positive high to moderate correlation with the getting along with people’s 
domain of the WHODAS 2.0    
1.5.2 Divergent hypotheses 
It was hypothesized that the total HDQ presence, severity and episodic nature 
would have a low correlation with the total score of the MOS-SS which assesses 
the social quality of life constructs which are not congruent with the construct of 
disability assessed by the HDQ.  
1.5.2 Known Group Hypotheses 
The HDQ was developed to assess disability in an aging group of PLWHIV with 
concurrent health conditions, who had been receiving ART over a period of time 
and who were no longer employed. It was hypothesised that the HDQ would 
assess different levels of severity and /or the presence of disability which would 
differ significantly for the known group variables of age, concurrent health 
conditions,  length of time on ART and employment status.  
1.6  SETTING OF THE STUDY 
The project was conducted at four different hospitals in Johannesburg namely: 
The Wits Donald Gordon Medical Centre, Helen Joseph Hospital, Chris Hani 
Baragwanath Hospital, and the Johannesburg Health District. Several factors 
influenced choosing these hospitals for the study, some of which are the intended 
generalisability of this study to the South African population, the sample size and 
also the accessibility to participants. 
Wits Donald Gordon Medical Centre which is the first private teaching hospital in 
South Africa was included as it represented people living with HIV from a high 
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socioeconomic status that were easily accessible. The HIV clinic forms part of the 
University of the Witwatersrand academic complex as do the clinics at Helen 
Joseph Hospital and Chris Hani Baragwanath Academic Hospital. 
Themba Lethu Clinic at Helen Joseph Hospital, Gauteng was selected as a 
research site as it is the largest national antiretroviral roll-out site in South Africa, 
and has been active since 2004 (Right to Care, 2010). The clinic is a part of the 
Medicine Department of Helen Joseph Hospital and Right to Care. Right to Care is 
a non profit organisation that provides prevention, care, and treatment for 
individuals living with HIV and associated diseases (Right to Care, 2010). More 
than 24,000 clients have been treated at this clinic, of which 14,000 patients have 
been initiated on ART (Right to Care, 2010). Patients from across Gauteng and 
from outside the province are served by this clinic due to the clinic’s high quality of 
care (Right to Care, 2010). Nthabiseng Thuthuzela HIV/AIDS Clinic at Chris Hani 
Baragwanath Academic Hospital is a government/public facility. It is a provincial 
primary health care facility that provides TB and HIV-related treatment, support 
services and care. The clinic has a client base of more than 5000 PLWHIV on 
ART from across Gauteng and outside the province. Participants attending 
outpatient clinics in the Johannesburg Health District in Hillbrow from a small 
informal drug rehabilitation group were also invited to participate in this study.  
1.6. JUSTIFICATION FOR THIS STUDY  
Studies by Hanass-Hancock, Regondi, van Egeraat, & Nixon, S, (2013) Hanass-
Hancock et al. (2015), Hanass-Hancock, Misselhorn, Carpenter, Myezwa, (2016), 
Myezwa Buchalla, Jelsma & Stewart (2011) and  Myezwa, Stewart, Musenge & 
Nesara (2009) and Rusch et al. (2004) have not only contributed to the 
understanding of disabilities experienced by PLWHIV but they have also revealed 
the need to have a valid assessment tool to measure these disabilities (Hanass-
Hancock et al., 2013.2015, 206, Myezwa 2011,2009). The result of this study will 
indicate the validity and reliability of the HDQ developed to identify disability in 
PLWHIV, for a sample of PLWHIV receiving ART in South Africa. The level of 
disability in the sample used in this study confirmed research about impairments, 
activity limitations and possible disability affecting  day-to-day activities and will 
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also give more insight or knowledge on the missing component in lives of PLWHIV 
in a developing country.  
The HDQ is the first HIV disability assessment tool to measure the uncertainties 
and episodic nature of disabilities experienced by PLWHIV. These concepts which 
are influenced by employment status, financial security, stigma and discrimination 
and length of time receiving ART which are perceived to be on high rise in sub-
Saharan Africa and most especially South Africa (Abrefa-Gyan, Cornelius, & 
Okundaye, 2016; Govender, Fried, Birch, Chimbindi, & Cleary, 2015; Hanass-
Hancock Myezwa & Carpenter, 2015a). Validating the tool in Johannesburg Metro 
area, South Africa will provide a basis for validation of the instrument in other 
African countries. The result of the study will also provide information to inform 
policy and research as well as support planning and implementation of 
rehabilitation programmes for HIV sufferers. 
1.7 OUTLINE OF THE THESIS 
Chapter 1 - Introduction 
Chapter 1 introduces the concept of disability specific to PLWHIV. The need to 
assess disability in PLWHIV and to validate the HIV Disability Questionnaire 
(HDQ) was also introduced. The statement of the problem indicated a lack of 
studies on disability in HIV in developing countries including South Africa, 
measured by an assessment specifically designed for PLWHIV. The objectives of 
the study were set out as well as the main aim to determine the validity and 
reliability of the HDQ. The layout of the rest of the study was also introduced.  
Chapter 2: Literature Review 
Chapter 2 contains a review of the literature relevant to the aims and objectives of 
the study. This literature is classified into two sections: literature related to 
disabilities, living with HIV and the effect of HIV on health and literature related to 
the assessment of disabilities in persons with HIV. Activity limitations, participation 
restrictions and quality of life are reviewed in detail in the first section of this 
chapter while construct validity, convergent and divergent validity, confirmatory 
factor analysis and reliability of the HIV disability questionnaire is discussed in 
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detail in the second section of this chapter. This chapter also reviews gaps in the 
literature that this study explored. 
Chapter 3 : Methodology  
This chapter discusses the empirical methodology adopted in this study. This 
involves discussion of the types of study and general design, choice of the study 
site and population, selection of samples and sample size, and measurement 
instruments. The research procedure which entails the languages used in data 
collection, training of research assistants and pre-testing of research instruments 
were also discussed. The data collection procedure is presented. This entails 
recruiting of participants according to ethical guidelines followed by administering 
of the questionnaires at the research sites. Data processing methods and data 
analysis plans are also presented.  
Chapter 4 : Results 
This chapter presents the results of the demographic characteristics of the study 
participants including age, gender, marital status and children, education, 
employment and disability grants as well as medical factors including CD4 counts, 
viral load, and WHO clinical staging were reported. The other sections of this 
chapter present the factor analysis and convergent and divergent validity of the 
HDQ against two reference assessment instruments, the difference in the level of 
disabilities experienced by participants in this study and known group variables 
were also reported. 
Chapter 5 : Discussions and Limitations 
This chapter is an overview of the findings of each objective of the study. It 
contains a detailed explanation of the study results according to aims and 
objectives of the study. Relevant literature was used to explain the outcome of this 
study which includes the demographic and medical outcomes, the validity and 
reliability of the HDQ and disabilities relevant to activity limitations and 
participations restrictions. Limitations were also drawn from the study which may 
have impacted on the outcomes in validating the HDQ for people living with HIV in 
South Africa.  
Chapter 6 : Conclusion and Recommendations 
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This chapter summarizes the study and the conclusions drawn from the outcome 
of the study on the validity of the HDQ. Several recommendations were made 
based on questions that remained unanswered for further studies in specific areas 
such as the validity of the observed high occurrence of episodic disabilities in 
PLWHIV in South Africa.   
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CHAPTER 2: LITERATURE 
REVIEW  
2.1 INTRODUCTION  
The literature review was carried out to provide information on the expected 
outcome of this study which aims to provide the first known valid assessment tool 
for the measurement of disability in PLWHIV in SA and it has two main sections. 
The first section deals with presentation of literature related to disability and living 
with HIV as well as the prevalence, types and impact of disabilities in PLWHIV in 
South Africa. The second section explores the validity and reliability of the HIV 
disability questionnaire (HDQ) by providing information on previous validation and 
reliability study, the limitations, the methodology used, and the outcomes. This is 
done to provide information on the expected outcome of this study which aims to 
provide the first known valid assessment tool for the measurement of disability in 
PLWHIV in South Africa. 
The following path was adopted to identify relevant literature for this chapter. 
Various research portals were accessed for journal and articles related to this 
study some of which are Clinical Key, Cochrane Reviews, Google Scholar, 
Pubmed, Science Direct, Scopus, Springer, Pedro Database and Wiley 
Interscience. Moreover, some websites were visited to gather more detailed and 
related information, some of which are Centre for Disease Control, Google, South 
African National AIDS Control, Medical Research Council, UNAIDS, World Health 
Organisation, and Canadian Working Group on HIV and Rehabilitation. Finally, 
review of textbooks and journals, research publications and abstract were also 
carried out to obtain more explanatory information on this research study. The key 
terms used for the search were HIV, disability, activity limitation, participation 
restriction, quality of life, HIV disability questionnaire, validity, reliability, WHODAS, 
medical outcome study social support survey. 
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2.2 SECTION 1: DISABILITY, LIVING WITH HIV AND THE EFFECT 
OF HUMAN IMMUNODEFICIENCY VIRUS ON HEALTH 
South Africa is facing a transition in health characterized by an escalation of free 
public access to antiretroviral treatment while the need for managing chronic 
infection as a result of the HIV persists. An increase in the prevalence of and 
disability exists in people living with the infection. 
2.2.1 Prevalence and Incidence Rates of HIV in South Africa  
The high prevalence of HIV in South Africa presents a significant problem for this 
country as according to UNAIDS, South Africa is reported to have the highest 
population of PLWHIV in the world (UNAIDS, 2014).  
Table 2.1: Human immunodeficiency virus Prevalence Estimates and 
Number of population living with Human immunodeficiency virus in South 
Africa (2002 – 2015) 
 
Year 
Prevalence Incidence 
Adults 
15-49 
(years) 
HIV 
population
(Millions) 
Women  
15-49 
(years) 
Adults 
 15-49 
(years) 
Youth  
15-24 
(years) 
Total 
population 
2002 16,69 14.50 6.75 8.8 1.65 4.02 
2003 16.85 14.58 6.35 9.0 1.63 4.14 
2004 16.93 14.62 6.07 9.1 1.65 4.25 
2005 17.01 14.65 5.91 9.2 1.67 4.35 
2006 17.22 14.82 5.82 9.4 1.65 4.51 
2007 17.52 15.10 5.76 9.7 1.58 4.71 
2008 17.81 15.39 5.71 10.0 1.50 4.93 
2009 18.09 15.66 5.69 10.2 1.43 5.13 
2010 18.29 15.87 5.70 10.4 1.38 5.32 
2011 18.42 16.01 5.64 10.6 1.34 5.48 
2012 18.53 16.14 5.61 10.7 1.31 5.65 
2013 18.67 16.29 5.60 10.9 1.28 5.83 
2014 18.85 16.46 5.59 11.1 1.23 6.02 
2015 18.99 16.59 5.59 11.2 1.22 6.19 
(Source: Stats SA, 2015) 
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Table 2.1 reveals the growth in the population living with HIV from 4.02 million in 
2002 to 6.89 million people in 2015 (Stats SA, 2015).  The South African National 
HIV Prevalence, Incidence and Behaviour Survey conducted in 2012 indicate that 
increased access to ART, which nearly doubled between 2008 and 2012, has 
resulted in higher numbers of PLWHIV living in the community. This and the 
incidence in the form of new infections accounts for the increased prevalence of 
HIV. 
The South African National HIV Prevalence, Incidence, and Behaviour Survey 
revealed that the HIV incidence rate, is still a concern, with new cases of HIV 
infection recorded in 2013 at 340,000 with a range of 310 000 to 370,000. The 
prevalence and incidence of HIV must be considered separately and although the 
prevalence of HIV has increased according to Stats SA, (2015) the incidence of 
HIV in South Africa has gradually reduced over the period 2002-2015. The 
incidence is also still an issue with SA, reported to have the highest number of HIV 
infections (UNAIDS, 2012). The population of people living with HIV is 6,300,000 
with a range of 6,000,000 to  6,500,000 (Granich, Williams, & Montaner, 2015). 
According to Stats SA, (2015), higher incidence of HIV is present among women 
between the ages of 15-49 when compared to men of the same age bracket (Stats 
SA, 2015). About 17% of reproductive woman in South Africa are HIV positive.  
Younger females aged 15-24 years showed a decline in HIV incidence (Stats SA, 
2015). This survey and reports by the Statistician General in 2015 reported a 
decline from 5.3 % to 2.1% in 2002-2005 and 2008-2012 in this age group (Stats 
SA, 2015). This indicates a marked reduction of about 60% in HIV incidence in 
younger women, which may bode well for lower prevalence rates in the future et 
al, 2014). This confirms the changing nature of the prevalence and incidence of 
HIV since the introduction of ART which is reflected in research showing a change 
in the health and mortality patterns over the last 15 years. 
2.2.2 Changing Health and Mortality Patterns in Individuals Living with 
Human Immunodeficiency Virus on Antiretroviral Therapy  
Human immunodeficiency virus disease has now been described as a chronic 
disease that is episodic in nature, within the present anti-retroviral therapy (ART) 
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era, instead of a terminal disease which it was regarded as before the introduction 
of ART (Nixon & Cott, 2000). This perceived change in the status of HIV has also 
brought about changes in needs related to living with a chronic condition, 
population, causes of death, disabilities and secondary complications of the illness 
in PLWHIV. The prevalence and causes of death in PLWHIV between the pre-
ART era and this current ART era have changed. This was further explored by 
Palella Jr, Baker, Moorman, Chmiel, Wood, Brooks, et al. (2006) and Granich, 
Gupta, Hersh, Williams, Montaner, Young, et al. (2013). Palella Jr et al. (2006) 
recruited 6945 participants with HIV through a prospective, multicentre, 
observational cohort study followed for a median of 39.2 months and reported a 
decline in death rate from 7.0/100 person-years of observation in 1996 to 1.3 
death/100 person years in 2004. This study also further revealed that although the 
AIDS related death rate reduced, non-AIDS related deaths increased 
proportionally from 13.1 percent in 1996 to 42.5 percent in 2004 where the most 
frequent were cardiovascular disease, pulmonary disease; hepatic and non-AIDS 
malignancy.  
From 1995-2013, ART has prevented 4.8 million deaths in southern Africa and 7.6 
million AIDS related death worldwide (UNAIDS, 2014). Granich et al. (2013) 
examined the HIV prevalence and annual AIDS death ratio in South Africa 
between 1990 and 2013 by using the United Nations Programme on HIV/AIDS 
(UNAIDS). They reported that South Africa has the second leading AIDS related 
death after Nigeria with 200,000 deaths related to AIDS and an uncertainty bound 
of 170,000 to 220,000 000. They also revealed that 30 in every 1000 people living 
with HIV dies from AIDS related causes (Granich et al., 2015).  
A study on changing causes of death and mortality rates for PLWHIV in Southern 
Alberta was carried out by Krentz, Kliewer & Gill (2005). They recruited 1987 
participants through a database search of primary care information for causes of 
death in patients documented to have had HIV between 1984-2003. They reported 
violence (3%), suicide (7%), cardiovascular disease (16%), hepatic disease (16%), 
non-HIV malignancies (19%) and drug overuse as the major causes of non-AIDS 
related deaths (Krentz et al., 2005).  
Sarfo et al. (2014) in their study at various clinics and hospitals in Ghana 
examined the co-morbid illnesses experienced by PLWHIV and classified them 
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into two groups, AIDS defining and non AIDS defining events. They recruited 4039 
participants, starting ART between 2004 and 2010. They reported 28.83 deaths 
per 1000 persons during the years in which they followed up on participantswith 
681  AIDS defining events were recorded per 1000 persons during these years of 
which TB and diarrhoea were the most common at 176(26.3%) and 155(22.8%) 
respectively. Fourty one non-AIDS defining events were recorded With 
cerebrovascular events 10(0.3%) and hepatic events 20(0.5%) being the most 
frequent (Sarfo et al., 2014). 
More recent research in high income countries shows that 50% of non AIDS 
deaths are due to cancer and cardiovascular disease as PLWHIV have a 50% 
higher risk for myocardial infarctions (Simmons, Ciancio, Kall,, Rice & Delpech., 
2013). In developing countries like South Africa TB is a major cause of death thus 
countries in Africa show a different picture with non AIDS deaths (Maartens, 
Celum, & Lewin., 2014). Because of stigma AIDS related deaths are under 
reported so there is no clear picture of AIDS related deaths and those that are non 
AIDS related (Parker & Aggleton, 2003) 
However, since the advent of ART and free public access to other HIV 
medications in South Africa, HIV is no longer viewed as a terminal illness but 
rather as a chronic disorder that is episodic in nature. Therefore, the life 
expectancy of PLHIV is now between 35.49-43.60 years for men and 34.09-41.88 
for women (Bhaskaran, Mussini, Antinori, Walker, Dorrucci, Sabin, et al., 2008; 
Johnson, Mossong, Dorrington, Schomaker, Hoffmann et al., 2013; Palella Jr et 
al., 2006; UNAIDS, 2013). 
The provision of ART, especially in South Africa, remains controversial due to the 
cost burden on the state with 42% (40%-44%) of the people living with HIV 
receiving medication for the disease (Granich et al., 2015). Provision of ART is 
presently based on the South African Antiretroviral Guidelines updated in 2013. 
These guidelines are based on the studies that have been carried out on when 
PLWHIV should start ART. The When to Start Consortium (2009); Hammer, Eron, 
Reiss, Schooley, Thompson, Walmsleyet et al. (2008) and South African 
Antiretroviral Guidelines updated in 2013 all indicated a CD4 count of about 350 
cells/millimetre cube as a level to introduce the treatment. The  South African 
Antiretroviral Guidelines updated in 2013 also suggested that irrespective of the 
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level of CD4 count, people with all types of TB, pregnant women and 
breastfeeding mothers, as well as those at WHO stage 3 and 4, are eligible to start 
ART. Breastfeeding mothers, patients with low CD4 count less than 200 
cells/microlitre, patients with TB/HIV comorbidities with CD4 count less than 50 
cells/microlitre, and patients with stage 4 irrespective of CD4 level require fast 
tracking  (i.e. ART initiation within seven days of being eligible) (South African 
Antiretroviral Treatment Guidelines, 2013).  The introduction of ART even at these 
late stages of HIV has significantly reduced the mortality rate, but it has been 
revealed a relative increase in the non-AIDS related death rate.  
Access to medication, health behaviour and adherence to medication still remains 
a problem among PLWHIV particularly in South Africa. Defaulting and poor access 
to ART was explored by Govender et al. (2015). They studied social assistance 
through disability grants and recruited 1200 patients on ART from which data was 
collected through an exit interview in two rural and two urban health sub district in 
four provinces in South Africa. The participants in their study in a context of 
chronic poverty and high unemployment revealed that paying for transport fees to 
get to the facilities was a barrier to accessing medication and adherence to 
medication (Govender et al., 2015). They found that while temporary disability 
grants are provided for PLWHIV with CD4 count less than 200 cells/microlitre and 
who cannot work because of a mental or physical disability, the administrative 
process for accessing disability grant was perceived as unnecessarily onerous by 
participants due to the poor knowledge of the administrative process among the 
health workers (Govender et al., 2015).  
In their study, 463 participants that were receiving the grant, 4.54% reported 
missing clinic while 9.72% reported missing medication dosages. Of the 804 
participants that are not receiving the grant, 5.86%  were reported as missing 
clinic visits while 16.10% were reported to be missing medication dosages. Their 
study provided evidence that grants provided for livelihood in impoverished 
PLWHIV as well as contributing to slightly better access to treatment and that 
discontinuation of a grant may result in deterioration of health and disability in 
these patients (Govender et al., 2015). 
Woolgar & Mayers (2014) carried out a study on benefits and adherence to 
treatment related to disability grants for PLWHIV in an informal settlement in 
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Western Cape. They showed that most participants in their study valued their 
health and remained adherent to ART even when their temporary disability grant 
was discontinued. It was reported that health professionals felt that patients 
exaggerated their disability status and defaulted on medicine in order to retain 
their grants, while patients reported they were denied grants due to the lack of 
health professionals understanding of disability related to HIV (Woolgar & Mayers 
2014, Simchowitz 2004). 
This revealed the need for health care providers to be aware of increasing 
incidence of conditions and disabilities related to living with HIV so as to screen, 
monitor, and treat such conditions (Hsue, Squires, Bolger, Capili, Mensah et al., 
2008). In terms of disability resulting from impairments, activity limitations, 
participation restrictions and decreased quality of life the need for valid measures 
of disability in PLWHIV in South Africa should be a priority. 
2.2.3 Activity limitations and participation restrictions of persons living with 
Human Immunodeficiency Virus 
The incidence and prevalence rates of HIV in South Africa do not sufficiently 
reveal the disability and health challenges facing PLWHIV. Disability, as stated by 
Convention on Rights of Persons with Disability, is a long-term impairment in 
physical, sensory, mental, and intellectual abilities which when in interaction with 
barriers limit their full and productive participation in society as others of their 
equal. This definition emphasizes not only the symptoms and diagnosis of the 
medical conditions but also the social and environmental conditions that contribute 
to the construct of disability (Vereinte Nationen, 2014). Disability has been 
conceptualised into three main categories: impairments, activity limitation, and 
participation restrictions, by the International Classification of Disability and Health 
(ICF) in order to understand disablement and the consequences of disease 
(Weltgesundheitsorganisation, 2001). The ICF obtained its strength not just from 
focusing on the biomedical concerns which centres on symptom and diagnosis but 
also on the social concern which focuses on how the biomedical challenges affect 
people’s lives and livelihood (WHO 2001). The ICF has therefore been useful as a 
framework through which disability related to HIV has been viewed since 1990 in 
Canada (Nixon & Cott, 2000; Worthington Myers, O’Brien, Nixon & Cockerill, 
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2005); Canada Working Group on HIV and Rehabilitation, 2011). However, using 
this same framework for conceptualising HIV in developing countries has only 
begun in the last 10 years.  
Activity limitation can be defined as the difficulties an individual may experience in 
executing activities (Üstün 2010). Another presentation of activity limitation is 
limitation experienced for a long time in performing usual day-to-day activities due 
to health problems (WHO, 2001). Activity limitations present in many different 
ways. These include limitations in self-care (bathing, grooming, toileting, eating 
and staying by oneself for few days), understanding and communication (learning 
new tasks, analysing and finding solutions to problems in day-to-day life) and 
physical activity (e.g. standing for two hours, walking up ten steps, carrying a ten 
pound object) (Weltgesundheitsorganisation, 2001). There are also limitations in 
engaging in recreation or social activities (e.g. visiting friends, sewing, going 
shopping, going to the cinemas, reading) with no assistance from a caregiver, 
another person or assistive equipment (WHO, 2001).  
Participation in daily activities may be defined as the ability to take part in society 
in terms of education, employment, and civic, social and family role participation 
as well as leisure in both environmental and socio-cultural context (Kindig, 2008; 
WHO, 2001). Any disturbance in participation was referred to as Handicap by the 
WHO in 1980, but recently, has been replaced with participation restriction (WHO, 
2001). 
The extended lifespan of PLWHIV has had an accompanying and corresponding 
increase in challenges in everyday activities which present as activity limitations 
and participation (Palella Jr et al., 2006). Myezwa et al. (2009) conducted a study 
using the ICF checklist on a sample of HIV-positive inpatients admitted to Chris 
Hani Baragwanath Hospital in Johannesburg, South Africa as a means of 
assessing the impairments, activity limitations and participation restrictions in 
patients living with HIV. They reported a high level of disablement among 80 HIV- 
positive inpatients and 45 HIV- positive outpatients (Myezwa et al., 2009). Activity 
limitations were found to be experienced by up to 35.5% of the population of 
PLWHIV even with free public access to ART (Govender et al., 2015; Hanass-
Hancock et al., 2015; South African Antiretroviral Treatment Guidelines, 2013). 
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More recently Myezwa et al. (2011) compared data from four different cross-
sectional studies that had applied the ICF. Three of these studies were carried out 
in South Africa and the last one in Brazil.The studies revealed issues across all 
groups including problems with sleep and weight maintenance (50%, 92/185), 
emotional functioning (49%, 185) and drive and energy (45%, 83/185) (Myezwa et 
al., 2011). Based on the results of this study, some participants reported pain as a 
major problem while some that have limited access to ART reported functional 
mobility as a problem (Myezwa et al., 2011). Gaidhane, Zahiruddin, Waghmare, 
Zodpey, Goyal, & Johrapurkar, (2008) also used the ICF to examine self-care in 
people living with HIV by recruiting 194 participants at a tertiary care hospital in 
rural India. They discovered more than 60% of the participant's experience one or 
more impairments in self-care (Gaidhane et al., 2008). This evidence points to the 
spectrum of disability, and it’s significant impact on activity limitations and 
participation in society but provides no information on health related quality of life 
(HRQoL) and how it is affecting PLWHIV on ART. Health related quality of life is 
related specifically to the impact of the person’s health status on their quality of life 
and participation in activities and society (Ferrans, 2005). 
2.2.4. Health-related quality of life in persons with HIV  
The WHO defines health as a state of mental, social and physical well-being and 
not just the absence of an illness or disease. A number of researchers, for 
example, McCall (1975), Myers (1987), Davidson and Cotter (1991), O’Brien and 
Ayidya (1991), Grayson and Young (1994), Diener and Suh (1997), Turksever and 
Atalik (2001) have studied on QoL and revealed that there are two dimensions to 
this concept; environmental and psychological dimensions. Grayson and Young 
(1994) showed that there seems to be an agreement that in defining quality of life, 
there are two fundamental sets of processes operating. The psychological 
component relates to gratification with life otherwise called individual or personal 
QoL, life satisfaction, or subjective well-being.The second environmental 
component is related to external conditions which trigger the internal mechanism 
otherwise called urban QoL, environmental QoL, community QoL, or quality of 
place. Since QoL is a broad concept, it is often argued that in defining it, these two 
dimensions should be considered. 
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The WHO definition of HRQoL supports the same components including the 
individuals understanding of their life roles and position in the context systems in 
which they live in relation to their expectations, goals, standards, and concerns 
(Hoffman, Wai, Thomas, Levin, O’Brien & Goldman 1992). This is a complex and 
multi-faceted concept affected by the person’s psychological state, physical 
health, and social relationships affecting their level of independence, personal 
relationships and ability to interact within their environments (Hoffman et al., 
1992). In PLWHIV HRQoL was affected by the introduction of ART due to the 
change of the condition from terminal to chronic (Mutabazi-Mwesigire, Katamba, 
Martin, Seeley & Wu, 2015). The challenges presented by this included the 
marked uncertainties PLWHIV faced for their future with feelings of hope but 
having to deal with social stigma, barriers to employment  and other health related 
issues (Rusch et al., 2004). 
Measuring HRQoL is probably the most subjective assessment in health practice 
in persons with chronic conditions as it reveals their perspective of the burden of 
the disease (Ramond-Roquin, Haggerty, Lambert, Almirall & Fortin, 2016). 
Furthermore, HRQoL has been evaluated in relation to many chronic conditions 
including chronic pain, multiple sclerosis, pancreatitis, chronic heart failure and 
primary hypertension and measures are not specific to one condition. The 
measurement of HRQoL is further complicated by the differences in these 
conditions which result in different impairments. With regards to HIV, and the 
advent of antiretroviral therapy, it is undoubtedly important to consider the HRQoL 
of patients with the HIV infection and the impact of the ART (Perez Baño, Ruz, 
Jimenez, Prados et al., 2005). 
2.2.4.1 Measurement of HRQoL 
Health related QoL in PLWHIV has been studied in the past few years by several 
researchers with many different instruments. These include instruments developed 
for the medical outcome study (MOS) and the instrument developed at Stanford 
University for the AIDS time-oriented Health outcome study, the Quality of Well-
Being Scale (Kaplan et al., 1984), the HIV Overview of Problems Evaluation 
System (HOPES), and the Functional Assessment of Human Immunodeficiency 
Virus Infection (FAHI) (Cella McCain, Peterman, Mo, & Wolen, 1996). Studies 
cited above have shown a marked reduction in HRQoL for PLWHIV, but little 
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information is available on the reliability and validity of these assessment tools 
when used with PLWHIV in resource limited environments.   
In 2008, O’Brien et al developed a conceptual framework and an assessment tool 
for disability related specifically to living with HIV which encompasses activity 
limitations, participation restrictions and HRQoL. The framework considers the 
“day-to-day health related consequences of HIV” which in their framework is 
conceptualised as disability. The authors felt the strength of the Episodic Disability 
Framework would be useful for clinicians, researchers and policy makers to 
understand the dimensions of HIV-related disability and the need for flexible 
policies in relation to grants and work.  
For PLWHIV the framework assists in explaining the experience of disability to 
health and care providers and can provide opportunities to develop strategies that 
may help with disability episodes over time. However, the framework was 
developed on an English speaking urban population who agreed to participate in 
the study which may have limited the perspective of disability. The severity of the 
participants’ HIV was also not analysed in relation to their disability. Testing to 
improve this and assess which aspects of the frame affect other groups needs to 
be carried out (O’Brien et al., 2008). 
2.3 DISABILITY IN PERSONS LIVING WITH HIV  
The real burden of HIV can be viewed in the light of disability-adjusted-life-years 
(DALY) which measures the “ years of life lost due to time lived in a state of less 
than full health”. It is thus to the sum total of years a person has been living with a 
disability (Bradshaw et al., 2003). According to the WHO (2009), HIV accounts for 
above 40 percent of the DALYs in South Africa in the year 2004. In light of this 
high prevalence of DALYs in PLWHIV, the provision of rehabilitation services to 
prevent and address disabilities in PLWHIV on ART or any other HIV medication 
has become an important consideration in HIV management. 
In order to measure disability in PLWHIV O’Brien et al (2015) based on their 
conceptual framework, developed an assessment instrument, the HDQ specifically 
for this population. The framework using a qualitative study identified three 
concepts related to disability in PLWHIV namely the constructs of impairments, 
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activity limitations and participation restrictions (O’Brien et al., 2008). These 
concepts include (1) episodic disability where fluctuations in the dimensions of 
disability on a daily basis and over the persons life present challenges in everyday 
activities, (2) contextual factors which may add to or reduce the dimensions of 
disability and (3) triggers or life events that result in major episodes of disability 
(O’Brien et al., 2008 O’Brien, Davis, Strike, Young & Bayoumi, 2009 ). Each 
concept will be considered individually in the next section. 
2.3.1 Dimensions of Episodic Disability  
Health related problems in PLWHIV may occur in episodes and may fluctuate from 
day to day or over months and years.  The initial concept in the framework was an 
Episodic Disability Framework consisting of four dimensions (O’Brien et al., 2008).  
The four dimensions of episodic disability were labelled based on the language 
preferred by participants living with HIV and the development of the framework 
was based on concepts in the ICF (O’Brien et al., 2008). The dimensions include 
(1) difficulties in carrying out activities of daily living which is similar to activity 
limitations, disability, and functional limitations, (2) impairment and symptoms 
which are synonymous to disablement at the level of body part, function and 
structure and (3) difficulties with social inclusion which are synonymous with 
handicap, disability and participation restrictions (O’Brien et al., 2008).  The fourth 
dimension added was that of uncertainty which considered worry and stress about 
the future due to the episodic nature of the condition. This was also sometimes 
associated with anxiety and depression (O’Brien et al., 2009). 
These four dimensions of disabilities are somewhat linked; that is the challenges 
in one or more of the dimensions is associated with the experience of another 
(O’Brien et al., 2008). 
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Figure 2.1 - Conceptual framework for episodic disability. O’Brien et al. 
(2008) 
 
O’Brien et al. (2008) reported that the episodic difficulties may fluctuate over the 
course of the day or the course of living with the infection over months and years. 
2.3.1.1. Symptoms and Impairments 
It has been revealed that disabilities experienced by people on ART may be as a 
result of the infection itself, side effects of the medication and other opportunistic 
infections (Nixon, Forman, Hanass-Hancock, Mac-Seing, Munyanukato et al., 
2011a; Rusch et al., 2004). Several immunodeficiency complications associated 
with inflammation have been observed by many researchers as an effect of the 
progression of the infection in people on long term ART calling for intense 
management of this disease and other disabilities (Hanass-Hancock et al., 2015; 
Myezwa et al., 2011; Nixon et al., 2011a; O’Brien et al., 2008; Rusch et al., 2004). 
In their study on disability in PLWHIV Rusch et al. (2004) found a third of 
participants had up to 10 multiple impairments and 91% of participants reporting at 
least one impairment. The participants CD4 counts were related to the number 
and type of impairments seen (Rusch et al., 2004). The most common impairment 
reported by 78.2% of participants were psychosocial and cognitive problems 
related to mental body functions. This finding  was supported by the findings of 
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sensory impairment by Hanass-Hancock et al., (2015) and Myezwa et al. (2009). 
Neuromuscular impairment was experienced by 49.5% of participants with other 
medical impairments being reported by 81% of participants admitted to hospitals. 
Pain of varying degrees was a problem for more than three-quarters of the 
participants (Myezwa et al., 2009). Similar findings were reported in a second 
study by Myezwa et al. (2011) where impairments were associated with a high 
level of activity limitations and difficulties with day to day activities. 
2.3.1.2 Difficulties with day to day activities  
Rusch et al. (2004) and Hannass-Hancock et al. (2015) researched activity 
limitations experienced by PLWHIV in different studies. Rusch et al. (2004) 
recruited 762 participants which was equivalent to 50.5% of PLWHIV in British 
Columbia through an anonymous survey sent out by email (Hanass-Hancock et 
al., 2015; Rusch et al., 2004). They reported on activity limitations and 
participation restrictions in 80.6% (607) of the participants with sexual activities, 
vigorous and moderate activities and household chores been most frequently 
reported disabilities (Rusch et al., 2004).  
In their study activity limitations were associated with CD4 count levels and 
reported 87.8% of the participants with a CD4 level below 200 cells/microlitre 
showed some limitations in activities (Rusch et al., 2004). Slightly fewer 
participants 77.4% in the group with CD4 counts between 200-500 cells/microlitre 
also reported some limitations in day to day activities while only 76.5% in the 
group with CD4 counts above 500 cells/microlitre reported some limitations. Using 
adjusted odds ratios of in mental function (18.71), laundry (8.41) and household 
chores (4.12) for those with CD4 level below 200 cells/ microlitre it was inferred 
that the participants with lower CD4 counts presented with more activity limitations 
as all odds ratio for those with CD4 level above 200 cells/ microlitre were below 
4.32(Rusch et al., 2004). 
Activity limitation in people living with HIV was further investigated by Hanass-
Hancock et al., (2015) by recruiting cohort of people (n=1042) who had been on 
ART for six months or longer in a semi-urban public hospital in South Africa.  They 
used the WHODAS 2.0 as their assessment instrument and also used a weighted 
score of two or more on the WHODAS 2.0 as an indicator of limitations (Hanass-
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Hancock et al., 2015). Their results showed that 50.19% of the participants had no 
limitation whatsoever, 14.20% had a weighted score of 1 on the WHODAS 2.0, 
14.88% had a weighted score of 2 and a weighted score of 3 on WHODAS 2.0 
was reported by 8.16% of the participants, while 12.57% of the participants 
reported a score of 4 or higher (Hanass-Hancock et al., 2015). While Rusch et al. 
(2004) and Hanass-Hancock et al. (2015) have mapped out the activity limitations 
in PLWHIV they found that these limitations may be associated with the high 
percentage of PLWHIV on ART who presented with depression in their studies.  
The results of the study by Rusch et al. (2004) needs to be interpreted with 
caution however as the sample under-represented people who are injection drug 
users, homeless, aboriginals and females and did not represent the people of 
other races apart from the Caucasians. The study by Hanass-Hancock et al. 
(2015) was also limited in that they did not map out specifically the types of activity 
limitations being experienced by the PLWHIV as they only classified limitations 
based on the six domains on the WHODAS 2.0 which include life activity, getting 
along, mobility, cognition, participation and self-care. Therefore there is a need for 
a more detailed study in a diverse population of PLWHIV. 
2.3.1.3 Challenges in Social inclusion 
The third dimension under episodic disability is challenges with social inclusion in 
the framework. Research by Rusch et al., (2004) based on the ICF framework 
explored the relationship between the different dimensions of disability, revealed 
that all activity limitations and impairments have a relationship with social role 
restriction. Their study indicated that the social role restriction had a very strong 
relationship with mental body functions (Rusch et al., 2004). Adjusted odds ratios 
in their study showed social role restriction were significantly related to 
impairments and activity limitations, most strongly to limitations in using the toilet 
followed by financial matters (Rusch et al., 2004).  
O’Brien et al. (2014), also echoed the correlation (r=0.88) between the social role 
restriction and mental-emotional challenges, which also supported the study by 
Rusch et al. (2004). Challenges to social inclusion according to the episodic 
disability framework have four components: personal relationships, parental roles, 
work and school and other social roles and activities (O’Brien et al., 2008). Stigma 
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and discrimination is another variable that has posed a challenge to social 
inclusion that has  been studied extensively by many researchers some of which 
are Eyles, Lee, & Birch (2014), Brittain Mellins, Phillips, Zerbe, Abrams, Myer et al. 
(2016), Chollier Tomkinson, & Philibert (2016) and Patel, Srivastava, Sharma, & 
Moitra (2016). Patel et al. (2016) in examining stigma and social inclusion, 
recruited 30 PLWHIV  in tertiary care in Surat city in the Indian state of Gujarat 
where 36.7% of the participants reported stigma and discrimination and about 
44% reported practice of health care providers taking extra precautions while 
providing treatment (Patel et al., 2016). Brittain et al. (2016) reported in their study 
on social support, stigma and antenatal depression in HIV-Infected pregnant 
woman in South Africa finding that social support and stigma are interrelated and 
associated with depressive symptoms. A  high level of stigma was discovered to 
have a moderate relationship with depression score and social support with no 
association observed between social support and depression scores (Brittain et 
al., 2016) . 
 
2.3.1.4 Uncertainty  
This domain of episodic disability has been described as a source of fear, anxiety, 
emotional distress and depression for people living with HIV. With the continuous 
increase in public access to ART, PLWHIV have extended survival rates and  are 
hence  faced with new uncertainties as they plan to live rather than avoid death 
(O’Brien et al., 2008). A high population of PLWHIV will have to reconstruct their 
identities not as a person living with a deadly disease but a chronic one and also 
renegotiate their life priorities (Brashers, Neidig, Cardillo, Dobbs, Russell, &  
Haas., 1999; Hanass-Hancock et al., 2015; Nixon et al., 2011; O’Brien et al., 
2008). Brashers et al. (1999) define uncertainty to be the “individual’s inability to 
give meaning to illness when outcomes are unpredictable and when the disease 
and its treatments and symptoms of care are highly complex, lacking information 
and ambiguous” this shows that the uncertainty with any chronic illness is as 
difficult as the impending death (Brashers et al., 1999:501). 
Mishel’s Uncertainty in Illness Trajectory, conceptualizes uncertainty as the 
interpersonal, social and emotional unknowns associated with illness progression, 
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diagnosis, and long term prognosis (Mishel, 1990). O’Brien et al. (2008) conducted 
a study to determine uncertainty in PLWHIV and discovered sources of uncertainty 
similar to that reported by Mishel. (1990) and Brashers et al. (1999) even though 
they did not try to find out if the participant could understand their illness unlike 
Brashers et al. (1999) they found out that participants in their studies could 
understand and communicate their uncertainty (O’Brien et al., 2008). 
2.3.2 Contextual Factors and Triggers of Disability  
The other two concepts of the framework developed by O’Brien et al. (2008) are 
contextual factors and triggers of disability.(O’Brien et al., 2008) 
2.3.2.1 Contextual Factors   
Contextual factors are regarded as the health related challenges in relation to the 
features that altered their experiences (O’Brien et al., 2008). Two groups of 
contextual factors have been identified in the ICF. In 2008, O’Brien et al. describe 
these factors in relation to PLWHIV with each having two subcategories namely 
extrinsic: social support and stigma; intrinsic contextual factors: personal attributes 
and living strategies. 
Extrinsic contextual factors are stigma and social support. O’Brien et al. (2008) 
stated that stigma results from discrimination from family, friends, employer, work 
colleagues, employers and health care providers due to the HIV status of people, 
ethno-cultural background, their sexual orientation, exacerbated disability, 
employment status and gender(O’Brien et al., 2008). They also stated that social 
support includes emotional and practical support received from family, friends, 
pets or partners and community; support from policy and programmes and 
personnel and health care support services. When these factors are considered 
from an HIV perspective the implications may be broader than for other chronic 
conditions and this was accommodated in the development of the HDQ 
particularly in terms of stigma and family and community support which is 
experienced internationally (O’Brien et al., 2008).  
Intrinsic factors include personal attributes and living strategies (O’Brien et al., 
2008). Non-modifiable characteristics are co-morbid illness inherent to an 
individual and age (O’Brien et al., 2008). Living strategies are attitudes, 
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behaviours, and beliefs people adopts in order to live with HIV and other 
opportunistic infections (O’Brien et al., 2008). These includes seeking and 
maintaining a sense of control over life and the illness, seeking communication 
with others, developing and adopting beliefs and attitudes to manage living with 
HIV and blocking HIV out of mind  (O’Brien et al., 2008). The strength of the use of 
these contextual factors in the assessment of disability in PLWHIV is that context 
can be linked to both disability and the episodic nature of the disability that occurs 
with HIV. This offers a new perspective on the intrinsic factors by offering a 
“foundation from which to build strategies to mitigate episodes of disability 
experienced by adults living with HIV” (O’Brien et al., 2009:10). 
2.3.2.2 Triggers of Disability   
Triggers for disability are life changing events which affect the person living with 
HIV that may result in impairments, activity limitations or  participation restrictions 
(O’Brien et al., 2008a). Four examples of disability triggers included: receiving an 
HIV diagnosis; experiencing a serious illness; suffering a loss of others and 
starting or changing antiretroviral medications (O’Brien et al., 2008). 
The view of disability as conceptualised by O’Brien et al.(2008) for PLWHIV 
emphasises the provision of rehabilitation services, to prevent and address 
impairments, activity limitations, participation restrictions in PLWHIV on ART or 
any other HIV medication (O’Brien et al., 2008). This is an important consideration 
in HIV management. Chetty and Hanass-Hancock in 2016 emphasised the need 
for decentralised rehabilitation services and concerns about the lack of major 
therapeutic disciplines like occupational therapy and the speech and language 
therapy services in this field of practice. (Chetty and Hanass-Hancock 2016) 
One of the major concerns in the rehabilitation field is to identify and validate 
assessment tools for disability in PLWHIV so that the prevalence and severity of 
disability in this population can be recognised and adequate interventions 
provided. This is also essential if effective services are to be delivered to this 
population. 
29 
 
2.4 SECTION 2:  ASSESSMENT OF DISABILITY IN PERSONS 
WITH HIV   
Both demographic information and standardised assessments are required to 
complete a full assessment of disability in PLWHIV. The demographic factors that 
are associated with disability in PLWHIV are reviewed first.  
2.4.1 Demographic Factors  
Demographic factors are known to be associated with HIV and disability (Hanass-
Hancock, 2015; Myezwa et al., 2009; Rusch et al., 2004). These include old age, 
low socioeconomic status, gender, educational level, and white ethnicity. In middle 
and low income countries, social support such as family support, support from 
friend and community at large are also revealed to be positively associated with 
activity level, social role inclusion and quality of life (Bauman Reis, Sallis, Wells, 
Loos & Martin, 2012). In sub-Saharan Africa industrialisation often results to 
growth in cities, leading to informal settlements that may lead to regression in 
health (BeLue Okoror, Iwelunmor, Taylor, Degboe, Agyemang,& Ogedegbe., 
2009). This result was further confirmed in research done in Khayelitsha by Belue 
et al. (2008), SA. Khayelitsha is a partial informal settlement in the Western Cape. 
The researchers noted that the inability to depend on a partner and lack of 
portable water in the home had the strongest association with perceived stress 
(BeLue et al., 2008). Transport and mobility stress often occurs in informal 
settlements (BeLue et al., 2009, 2008). It is therefore to be expected that 
environmental factors such as accessibility (transport, distance, and mobility) are 
associated with activity level, social role participation, and quality of life in 
individuals living in low- and middle income countries (Bauman et al., 2012).  
2.4.2 Assessment tools 
While many tools used for assessment of disabilities in PLWHIV for example 
WHODAS 2.0 and MOS-SSS, had been developed before the era of ART which 
has changed the course of HIV from a terminal disease to a chronic illness (Palella 
Jr et al., 2006) other recently developed assessment tools for example the HIV 
specific HRQoL questionnaire focuses on employment and social relationships 
(Duracinsky, Herrmann, Berzins, Armstrong, Kohli, Le Coeur, et al., 2012a; 
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Duracinsky, Lalanne, Le Coeur, Herrmann, Berzins, Armstrong et al., 2012b) are 
now available. The scope of these tools such as values, goals and expectation 
goes beyond the scope of disability and the tools were not developed to evaluate 
the episodic nature of the disability experienced by PLWHIV. 
Other instruments such as the Brief-Coping with Problems Experienced (COPE), 
HIV stigma scale, the Centre for Epidemiological Studies Depression Scale and 
the HIV Symptom Index have been used in relation to determining disability in 
PLWHIV. Assessment tools that have been used in research to assess activity 
limitations and HRQoL of PLWHIV include the WHODAS 2.0 and MOS-SSS and 
the HDQ developed specifically to be used with PLWHIV.   
2.4.2.1 World Health Organization Disability Assessment Schedule 
(WHODAS 2.0)  
This is a generic, practical assessment instrument that measures health and 
disability in a clinical practise or at a population level (Üstün, 2010). WHODAS 2.0 
conceptualise functioning into six domains, cognition (understanding and 
communicating), mobility (moving and getting around), self-care (dressing, eating, 
hygiene and staying alone), getting along (interactions with other people), life 
activities (work, leisure, domestic activities and school), and participation 
(participation in society and community activities) (Üstün, 2010).  
Many measures of disability have already been published; they are sometimes 
regarded as functioning measures and health status measures (Üstün, 2010). 
Aspects that make WHODAS 2.0 different are (1) direct link to the ICF as it covers 
ICF domains and applies to all diseases (2) cross-cultural comparability, (3) 
psychometric properties and (4) ease of use and availability (Üstün, 2010). 
Reliability and validity of the WHODAS 2.0 have been carried out in  different 
geographical representations of WHO regions (taking into account cultural and 
linguistic variation) some of which are Nigeria, United States of America, Greece, 
and Luxemburg to mention a few. The assessment tool has good construct validity 
with confirmatory factor indicating that the six domains are independent of each 
other. Test-retest reliability is adequate concurrent validity to Medical Outcomes 
Study’s 36-Item Health Survey (SF-36), the Functional Independence Measure 
(FIM), World Health Organization Quality of Life Instruments (WHOQOL-100 and 
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WHOQOL-BREF), in different populations. The internal consistency is between 
0.94 and 0.98 for the various domains (Üstün, 2010). 
Different versions of the WHODAS 2.0 exist, and these include three 36 item 
versions (interview-administered, self-administered, and proxy-administered), 
three 12 item versions (interview-administered, self-administered, and proxy-
administered) and one 12+24 item version in interview format (Üstün, 2010). 
Scoring of the WHODAS 2.0 both the short and full versions involves two basic 
options: simple and complex scoring (Üstün, 2010). The simple scoring system 
involves summing of the assigned numbers to the item on the questionnaire (1), 
‘none’ (2), ‘mild’ (3), ‘moderate’ (4), severe (5), extreme while the complex scoring 
method takes into account multiple levels of difficulty for each WHODAS 2.0 item, 
therefore, allowing analysis that makes use of the full information of the response 
categories for comparative analysis subpopulation and population at large (Üstün, 
2010). 
Handling missing data within WHODAS 2.0 involves two approaches: simple and 
complex approach (Üstün, 2010). The simple approach varies based on the 
version of WHODAS 2.0. For the 12 item short Version, when one item is missing, 
the mean of other items is used to assign a score to the missing item. When 
working with WHODAS 2.0 full version, if a participant is not working and has 
given a response to 32 items, the score can be used as it is and then compared 
with that of the 36 item version. The Complex approach is used when working with 
large data sets where more than one or more than two items are missing in the 12 
item and 36 item versions respectively (Üstün, 2010). 
2.4.2.2 Medical Outcome Study Social Support Survey (MOS-SSS)   
The MOS-SSS is a brief, self administered, multidimensional questionnaire 
developed to assess social support in a medical outcome study (Sherbourne & 
Stewart, 1991). The MOS-SSS contains 19 functional support items, arranged in a 
5-point linkert type scale, closely related to different dimension of social support: 
(1) information support (guidance, advice, information, or feedback- 4 questions) 
(2) affection support (affection and expression of love-3 Questions) (3) positive 
social interaction (affection and expression of love- 3 questions) (4) tangible 
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support  (provision of behavioural assistance, medical aid- 4 questions) and (5) 
emotional support (Sherbourne & Stewart, 1991). 
Five answer options are available for every question on the assessment tool: 
‘none of the time,’ ‘a little of the time,’ ‘some of the time,’ most of the time,’ and ‘all 
of the time’. In addition to social support, the MOS-SSS have two items that 
evaluate social network (number of relatives and close friends) (Sherbourne & 
Stewart, 1991). The MOS-SSS has 3 different versions: 18, 12 and 4 items 
versions and score on each scale is calculated as a percentage of the maximum 
score possible in that dimension (Gjesfjeld et al., 2007; Sherbourne & Stewart, 
1991). 
Various studies have been carried out to determine the reliability and validity of 
MOS-SSS. According to Sherbourne et al. (1991) the MOS-SSS has a high 
internal consistency (Cronbach’s alpha = 0.97 and sufficient test- retest reliability 
α=0.78). Soares et al. (2012) assessed the psychometric properties of the MOS-
SSS Brazilian Portuguese version in a survivors of Hodgkin’s lymphoma (HL) and 
reported that item-correlated person correlation coefficient between items and 
their dimension range from 0.57 to 0.76, internal consistency assessed using 
Cronbach’s alpha was 0.95 for the overall scale and varying from 0.78 to 0.87 for 
the 5 subscales. In addition, an exploratory factor analysis yielded a 3- factor 
solution, positive social interaction, aggregating affection, and informational and 
emotional dimensions of social support (Soares et al., 2012). 
 
2.4.2.3 HIV Disability Questionnaire   
This questionnaire was developed by O’Brien et al. (2014) specifically to assess 
the disabilities of PLWHIV in view of the extended life span and aging in this 
population. Persons living with HIV are experiencing episodes of illness and 
wellness associated with adverse effect of the antiretroviral therapy, the disease 
itself and other opportunistic infections (Gaidhane et al., 2008; Weiss et al., 2010; 
Willard et al., 2009). In light of this, disability has become as important as mortality 
in this population (Üstün, 2010).  
Developed by O’Brien et al. the HDQ is a self-administered questionnaire that 
assesses the nature of disability experienced by PLWHIV on three scales namely 
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severity, presence and episodic scales. The HIV disability questionnaire is the first 
HIV specific disability measure to be developed based on a conceptual framework 
that examines disability experienced by PLWHIV (O’Brien et al., 2014). O’Brien et 
al., (2015) developed the HDQ to assess disability in men from an urban area who 
had been living with HIV and taking ART. The assessment was validated on 
participants with concurrent health conditions who were not working.  
The internal consistency, construct validity, and test-retest reliability of this new 
HIV specific questionnaire was further investigated by O’Brien et al. (2015) in an 
international study  on PLWHIV in Ireland and Canada. The sample consisted of  
235 adults (18 years and older) living with HIV recruited from hospital clinics, and 
AIDS services organisation and administering the HDQ with seven other reference 
measures namely; WHODAS 2.0, SF-36, MOS-SSS, HIV Symptoms Index, HIV 
Stigma Scale, COPE, Centre for Epidemiologic Studies Depression Scale (CES-
D).  O’Brien et al. (2015) calculated the HDQ disability presence, severity, episodic 
scores (scored from 0-100). They reported a Cronbach’s alpha score of between 
0.97 and 0.96 for the severity and episodic scales in Canadian and Irish studies 
respectively.  
Construct validity was assessed using 40 a priori hypotheses of correlations 
confirming both convergent validity and divergent validity with the seven reference 
instruments mentioned above. Of these 32 (80%) were supported in the Canadian 
study and 22 (55%) were supported for the Ireland participants (O’Brien et al., 
2015). Test-retest reliability ranges from ICC values of 0.80 to 0.89. 
O’Brien et al. (2015) concluded that the HDQ is valid and reliable in Canada and 
Ireland. There were significant differences in the presence, severity and episodic 
scales for the two countries due to known group demographic and medical 
variables in the two samples. The participants in Ireland differed from those in 
Canada in that they were younger, they had fewer concurrent health conditions 
and approximately 50% were employed. The median time since diagnosis with 
HIV of the Canadian sample was also eight years earlier than that of the Irish 
sample so the Canadian participants had been living with HIV for much longer.  
 The developers of The HDQ stated that the results of this validity study cannot be 
generalised as the study was completed in resource rich countries necessitating a 
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validation study of the HDQ in a resource limited environment such as Such 
Africa.  
2.5 CONCLUSION 
Human immunodeficiency virus infection is a significant health related issue in SA, 
with prevalence high in both genders between the ages of 15-49 and more 
common among women. With local ART initiation guidelines now being aligned 
with those recommended internationally, the mortality rate in PLWHIV could be 
reduced with a corresponding increase in the number of PLWHIV developing 
disability. Disability rate in PLWHIV has already been reported to be high in 
PLWHIV in South Africa. Both national and international data has revealed that 
impairment; activity limitation and participation restriction in PLWHIV may be 
related with a corresponding decline in quality of life. In light of the need for 
rehabilitation services to prevent, control and manage disabilities in PLWHIV as 
the burden related to HIV is greater in South Africa than in other parts of the world. 
The HDQ was develop but requires validity and reliability in a resources limited 
country. 
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CHAPTER 3: METHODOLOGY  
3.1 INTRODUCTION 
In this chapter, the empirical research methodology is presented including the 
study design, study population and criteria for selection of participants in the 
study. Ethical considerations and data collections tools, data methods and data 
analysis are also presented. 
3.2  TYPE OF STUDY AND GENERAL DESIGN  
A quantitative, descriptive, cross-sectional research design was used. This is a 
study design that aims to provide data on a selected sample of the population of 
PLWHIV. It is a suitable design for this observational study where variables will not 
be manipulated but instead, some feature of the sample, such the presence, 
severity and episodic nature of disability in PLWHIV will be described (Kielhofner, 
2006). A cross-sectional study compares persons at a single point in time. This is 
a quantitative descriptive study as the relationships between variables will also be 
compared. 
The validity of the HDQ for the South African sample were also determined using a 
correlation study design.  The convergent and divergent validity of the HDQ with 
other instruments assessing activity limitations and quality of life were determined.  
3. 3. STUDY SITES AND POPULATION  
3.3.1 Study sites 
Four study sites were chosen because of various factors. Some of the factors 
were to provide diversity in the sample and supported the intended generalisability 
of this study by including hospitals from the suburban, and townships areas to 
reflect not just the distribution of disability between the different socioeconomic 
groups but also the racial distribution of HIV and accompanying disabilities. The 
vicinity of all sites which was within a 20km radius of the University of the 
Witwatersrand Education Campus based on convenience sampling for the 
researcher in terms of transport. Helen Joseph Hospital (Themba Lethu Clinic) 
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and Chris Hani Baragwanath Hospital (Nthabiseng Thuthuzela Clinic) and the 
Donald Gordon Medical Centre and a fourth site involved individuals associated 
with a drug rehabilitation support group were the sites where participants were 
recruited (see Chapter 1).  
3.3.2 Population  
The participants in this study were adults with HIV who have been on ART for six 
months or longer. People living with HIV who attended Helen Joseph Hospitals 
(Themba Lethu Clinic), Chris Hani Baragwanath Hospital (Nthabiseng Thuthuzela 
Clinic), an informal drug rehabilitation support group and Donald Gordon Medical 
Centre between June and July 2016 was included in this study.  
3.3.3 Sample selection  
The sample was conveniently selected among individuals living with HIV, on ART, 
living in Johannesburg Metro, South Africa.   
3.3.4. Inclusion criteria:  
Participants had to be 
 Adults (18 years and above)  
 Persons with HIV and on antiretroviral medication for six months or longer 
 Must be able to answer self-report questionnaires independently or in an 
assisted interview format  
3.3.5 Sample size 
The sites used to recruit participants, provide services to approximately 11,000 
individuals and according to Cochrane’s formula for a survey sample size of a 
minimum of 400 participants, would provide a statistically representative sample of 
this population, with an acceptable error at 5% (p=0.05) for the categorical data 
used in this study (Barlett et al., 2001). This sample size was also adequate for the 
factor analysis where a suggested 3-6 subjects-to-variables ratio recommended by 
Arrindell & van der Ende (1985) indicating a sample size of 350 with a ratio of 5:1 
should be included for the 70 items on the HDQ. The sample was larger than the 
minimum sample of 250 they recommended (Arrindell & van der Ende 1985). The 
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choice of approximately 5 participants per item on the HDQ was used as the ratio 
of 2:1 – 5:1 is reported more often in the literature (25.8%) in PsychINFO articles 
than any other ratio (Costello, A& Osborne 2005).  
The sample size was adequate for the convergent and divergent validity of the 
HDQ as based on the sample size calculation used by O’Brien et al (2015) in 
which they required weak correlations of 0.3 to show significant divergence 
between the HDQ and Medical Outcomes Study Social Support MOS-SSS) at a 
power of 90%. 
3.4.  ASSESSMENT INSTRUMENTS 
The following instruments were used: a demographic questionnaire, HDQ and 
WHODAS 2.0 to assess activity limitations and participation restrictions and the, 
MOS-SSS to assess quality of life related to social support. 
3.4.1 Demographic questionnaire  
A demographic and medical history questionnaire was developed by the 
researcher (Appendix A) and in view of the demographic factors affected by HIV 
reviewed in the literature the following variables were added to the demographic 
questionnaire: questions pertaining to age, sex, marital status for information 
regarding support, comorbidities, current employment status, monthly income 
and/or grants received by participants; housing environment for an estimation of 
size of housing and transport. 
The questionnaire consisted of fourteen questions in two categories: personal 
background and medical history. Questions to assess variables such as age, 
gender, marital status and the number of children they have were presented first. 
The highest level of education and employment status was also established.  
The questionnaire was piloted for content validity by giving it, together with the 
study aims and objectives, to two professors of medicine with academic and clinic 
experiences in HIV populations for review. Their suggestions and comments were 
implemented and minor adjustments made accordingly. 
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Three questions were added indicating if the participants are receiving the 
disability grants or not, confirming the period since the antiretroviral therapy was 
initiated and the recording of the participants’ viral load. 
Information about illnesses, surgery, CD4 counts, viral load and length of time on 
ART was confirmed where possible by reviewing the participants’ clinic files. 
Participants were asked to give permission for the file to be consulted if it was 
available.   
3.4.2 HIV Disability Questionnaire (HDQ)  
The HDQ is a 69 item questionnaire which comprises of six domains: physical, 
cognitive, mental and emotional health symptoms and impairments, difficulty with 
activities of daily living, barriers to social participation, and uncertainty (Appendix 
B).  
Table 3.1 Structure of the HIV  Disability Questionnaire  
Domain Physical 
symptoms 
and 
impairments 
Cognitive 
symptoms 
and 
impairments 
Mental and 
emotional 
health 
symptoms 
and 
impairments 
Uncertainty 
(or worry 
about the 
future) 
Difficulty 
with day‐
to‐day 
activities 
Challenges 
to taking 
part in 
social and 
community 
life 
1 2 3 4 5 6 
Number 
of items 
20 items 3 items 11 items 14 items 9 items 12 items 
 
Item 70 on the HDQ allows for the PLWHIV to report whether they are having a 
good or bad day at the time they filled out the questionnaire (O’Brien et al., 2015). 
The HDQ measures the presence, severity and episodic nature of disability 
experienced by PLWHIV and scores from these measures are transformed to a 
score of a linear range of 0-100. The HDQ was developed on a five point Likert 
type scale from 0-4.  
The HDQ is scored from the Linkert scale in three different methods to determine 
the presence, severity and episodic nature of disability  
Scoring:  
a. Presence scale 
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For the presence scores, the results of each domain of the HDQ is scored by give 
0 (not present) where PLWHIV indicates no disability and 1(present) where 
PLWHIV indicates disability against each item irrespective of severity. The 
presence of disability score is calculated by determining the number of items 
where disability is marked present against the total number of items answered and 
multiplied by 100.  
 
b. Severity Score  
For the severity scores, each domain score is added up based on the score from 0 
to 4 calculated by dividing the total possible score for that domain which is the 
number of items answered multiplied by four which is the highest possible score 
for any item. The final score is multiplied it by 100. The total severity score is 
calculated by summing the total domain scores and dividing it by the total number 
of domains which is six. 
c. Episodic scale  
The HDQ episodic scale has a Yes or No option for each of the 69 items on the 
scale. The episodic nature of disability score is calculated by determining the 
number of yes responses indicating fluctuation in disability which are divided by 
the total number of responses and multiplied by 100. 
Each of the six domains of the HDQ is scored separately for each scale and then 
a total score for each scale was calculated by summing the total scores of these 
domains and dividing it by the total number of domains, thus resulting in three 
different scale results for the HDQ. 
3.4.3 World Health Organisation Disability Assessment Scale (WHODAS-2)  
The WHODAS-2 contains 36 items that assess disability in six domains (Appendix 
C). 
Table 3.2 Structure of the World Health Organisation Disability Assessment 
Scale 
Domain Mobility Cognition Self 
care 
Getting 
along with 
people 
Life activities 
(domestic, 
leisure, work 
and school) 
Participation 
in society 
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1 2 3 4 5 6 
Number 
of items 
6 items 5 items 4 items 5 items 8 items 8 items 
 
Scores range from 0-100, where 0 indicates an absence of disability across all 
domains while 100 shows full disability (WHO, 2001). The WHODAS 2 has validity 
and reliability for individuals with chronic conditions (Kemmler et al., 2003).  
A complex scoring approach is utilised for the WHODAS 2.0 based on item 
response  theory (IRT)  (Üstün, 2010). Each item on the WHODAS 2.0 was coded 
as “none”, “mild”, “moderate”, “severe” and “extreme” separately the summary 
score was determined by differentially weighting the items and the levels of 
severity.  
The scoring uses three steps: 
Step 1- summing of recorded items scores in each domain 
Step 2- summing of all the six domains 
Step 3- converting the summary scores into a score ranging from 0-100 
The WHODAS 2.0 therefore has a domain specific score for each six domains: 
mobility, self-care, cognition, getting along, life activities (household and work) and 
participation restrictions as well as a total score. 
3.6.4 Medical Outcomes Study Social Support Survey (MOS-SSS)  
This MOS-SSS assessment tool contains 20 items which focuses on assistance, 
companionship or other types of support availability when needed (Appendix D). 
Scores on this assessment instrument also range from 0-100 with 0 indicating no 
available support when needed and 100 indicating assistance is always available 
when needed. This tool shows construct validity and reliability when used with 
PLWHIV (Sherbourne, et al., 1991). 
Table 3.3 Structure of the Medical Outcomes Study Social Support Survey 
Domain Emotional and 
informational 
support 
Tangible 
support 
Affectionate 
support 
Positive social 
interactions 
1 2 3 4 
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Number 
of items 
8 items 4 items 3 items 3 items 
 items 3, 4, 8, 9 
13, 16, 17, and 
19 
items 2, 5, 12 
and 15 
items 6, 10, 
and 20 
items 7, 11, 
and 18 
 
An additional item, item 14 is scored alone. A complex scoring method was used 
for the MOS-SSS.  The scores for each of these items are converted to a score of 
metric range from 0-100 by dividing the total scores by the maximum possible 
score and dividing by 100. 
 To calculate each domains scores, item scores were summed and divided by the 
total number of items in the domains while the total MOS-SSS score was 
calculated by adding the total domain scores and dividing it by the total number of 
domains. 
3.5 LANGUAGE USED IN DATA COLLECTION AND TRAINING OF 
RESEARCH ASSISTANTS 
3.5.1 Language review 
South Africa has 11 official languages: Afrikaans, English, isiNdebele, isiXhosa, 
isiZulu, Sesotho sa Leboa, Setswana, siSwati, Tshivenda and Xitsonga. The 
lingua franca of the country is English, due to it being the language of business, 
media and politics (Stats SA, 2011). Most frequently spoken languages at the 
study sites, where this research was conducted in Gauteng province are isiZulu 
(19.8%), English (13%), Afrikaans (12.4%) and Sesotho (11.6%) (Stats SA, 2011).  
According to Ballington et al. (2012) and Wood, Hanrahan, Coetzee, Koekemoer 
& Brooke, (2010) in two unpublished PhD theses from the University of the 
Witwatersrand subjects in research studies in Gauteng province, prefer to provide 
information in English and very rarely select to provide information in their home 
language (Ballington et al., 2012; Wood et al., 2010). Therefore, data capturing 
forms, information sheets and consent forms were kept in English.  
However the possibility did exist that patients at the clinics even though they might 
speak some English would not be comfortable reading and completing self-report 
questionnaires unassisted in English. Therefore, research assistants fluent in 
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isiZulu which is commonly spoken in Gauteng Province were recruited to assist 
participants with understanding questions on the self-report questionnaires used in 
this study. They also explained the contents of the information sheets and the 
consent forms to participants who did not read or understand written English. 
3.7 RESEARCH PROCEDURE   
The project was submitted to the University of the Witwatersrand’s Human 
Research Ethics Committee (HREC), and ethical clearance was granted 
(clearance certificate M160407 (Appendix E)  
 The project was approved by the Faculty of Health Sciences of the University of 
the Witwatersrand Permission to conduct the project at The Wits Donald Gordon 
Medical Centre (May 2016), Helen Joseph Hospital (June 30) and Chris Hani 
Baragwanath Hospital (July 2016) was received from the hospital management 
followed by consultation with the medical manager of the clinics for written 
permissions (Appendix F). The participants associated with the drug rehabilitation 
group who attended Hillbrow Clinic were approached on an individual basis 
Before data collection was started, four research assistants were recruited and 
trained to assist with translation and reading of the questionnaire for participants 
who needed help in understanding the questions. Adequate training was given to 
the research assistants so they did not expand on question but delivered the exact 
question. 
Times that were suitable to the clinic were determined with the mangers for data 
collection to take place and arrangements were made for the staff at the clinic to 
recruit patients into the study as requested by the ethics committee. 
3.7.1 Training of research assistants 
Four research assistants were recruited for this study, two of whom assisted with 
data collection at the Themba Lethu Clinic, and another two who assisted with 
data collection at the Nthabiseng Thuthuzela Clinic. Two of these assistants were 
students at the University of the Witwatersrand while the other two were students 
at the University of Johannesburg.  
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All the research assistants were recruited for their language skills as they were 
fluent in English and isiZulu. One research assistant could also speak eight other 
South African official languages fluently including (isiZulu, Tsonga, Tswana, 
Venda, Ndebele, Xhosa, Swazi, and Northern Sotho) and another was fluent in 
isiXhosa. 
Training sessions were held with the research assistants and the study aims and 
objective were discussed with them and their role in assisting with data collection 
was explained. They were provided with a document with the most important facts 
to remember when assisting participants to complete the questionnaires. The four 
assistants were also made familiar with the consent forms and information 
documents. The data capturing forms, consent forms and information documents 
were translated into isiZulu verbally by each research assistant which was 
recorded by the researcher. The recorded translated information was given to two 
researchers who are PhD students at the Department of Public Health University 
of the Witwatersrand and who understand isiZulu with the English version. They 
translated the information back into English and identified the best verbal 
translations of the questions and information sheet. The research assistants were 
provided with a copy of these verbal translations to listen to and follow during data 
collection.  
3.7.2 Pre-Testing of research instruments  
The research instruments were pre- tested for a week prior to the collection of 
data followed by an update of the demographic questionnaire. The questionnaires 
were pre- tested with 10 individuals (HIV status unknown) five of whom are fluent 
in English and five who were not. The aim was to assess the feasibility, the 
simplicity, the deficits and the weakness of the demographic questionnaire before 
it was finally implemented in the study as well as determine the time it took to 
complete all four research instruments with and without assistance. This pre-test 
was carried out with the research assistants and this helped them get familiar with 
the administration and interpretation of some of the questionnaires. 
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3.7.1 DATA COLLECTION PROCEDURES    
The directors of the HIV clinics at the hospitals were consulted. Verbal permission 
was received to use a room at the clinic for data collection and for staff to recruit 
patients for the study. Participants were approached by the clinic staff and 
provided with an information sheet (Appendix G) so they could understand the 
purpose of the study. They were asked to sign informed consent (Appendix H).  
This was followed by administration of the self-report questionnaires in the 
following order: 
 Demographic questionnaire. 
 HIV Disability Questionnaire. 
 The two reference questionnaires: The WHODAS 2.0 and the then the 
MOS-SSS. 
Participants were asked by the researcher to complete the questionnaires 
themselves if possible or to request the help of a research assistant for translation. 
Participants were moved to a quiet area in the clinics at a table to complete the 
questionnaires by themselves or with the help of a researcher.  
3.7.3 Data processing methods and data analysis plans 
The researcher closely supervised the research assistants during data collection. 
The researcher also checked some of the questionnaires to identify omitted fields. 
Missing data was collected immediately while participants were still available. Four 
questionnaires were eliminated because two of the participants did not meet the 
inclusion criteria and two were excluded because more than 10% of the data was 
missing. Data was cleaned and  put onto an Excel spreadsheet (2007) and 
analysed using Stata 13 and Statistic v 12.  
3.7.4 Data management 
Data was entered onto Excel spreadsheets on completion of data collection. 
Scores for the HDQ were calculated so that the scores for the presence, severity 
and episodic scales were reflected as a score out of a total of 100. The score for 
the WHODAS 2.0 and the MOS-SSS which is an equivalent of the total severity 
score of the HDQ was also converted into a metric score ranging from 0-100 for 
easy interpretation and correlation with those of the HDQ. 
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3.8 ETHICAL CONSIDERATION DURING THIS STUDY  
Project particulars were explained to participants by four research assistants 
during recruitment, and participants were provided with an information sheet to 
confirm the requirements of the study. They were asked to sign two informed 
consent sheets, one to participate in the research and another one to give 
permission for their file to be accessed for information on CD4 counts and viral 
load. The information document (Appendix G) and consent forms (Appendix H). 
Participants’ names collected on the informed consent sheets were kept separate 
from data-capturing forms to ensure anonymity. During data collection and 
analysis study participants’ names were used for identification purposes. 
Consultations with participants were held in a private room in the clinic to ensure 
privacy and the same procedure was repeated for all participants to ensure 
standardisation.   
3.8.1 Consent 
Informed consent was sought from the participants before the questionnaires were 
administered. Participants were informed of the voluntary nature of the study and 
that they could withdraw from the study at any time if they so wished without 
affecting their medical treatment or any other benefit. 
3.8.2 Confidentiality 
The data collection procedures took place in five rooms two at the Themba Lethu 
clinic, and three at both the Nthabiseng Thuthuzela Clinic and the Donald Gordon 
Family Medicine Clinic. Individuals associated with the drug rehabilitation 
programme were provided with questionnaires and completed them at home and 
returned them in a blank file to the researcher. No names were used at Themba 
Lethu Clinic, Hillbrow Clinic and Donald Gordon Clinic, but names were collected 
at Nthabiseng Thuthuzela Clinic for specific file identification alone and were not 
included in the data capturing form. 
3.8.3 Non-maleficence 
The principles of non-maleficence were applied in this study by ensuring that the 
information was not used to harm the participants in anyway and the benefits that 
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the study will have for the University of the Witwatersrand, the community and the 
participants is in terms of knowledge. 
3.9 DATA ANALYSIS 
3.9.1 Demographic data 
Data was analysed using descriptive analysis involving frequency, and 
percentages for the demographic and medical history data. Data for demographics 
that were described included age, education, marital status and number of 
children as well as CD4 counts, viral load concurrent medical conditions and 
period of time they have been on medication. 
Descriptive results were used to analyse the results of the HDQ, WHODAS-2 and 
the MOS-SSS for the sample of 498 participants. Median scores were presented 
as the data were ordinal in nature and not normally distributed to describe the 
disability for the participants on the HDQ, WHODAS-2 and the quality of life of the 
participants on the MOS-SSS. Mean and standard deviation for the scores were 
also presented as some median scores were 0 and the means were included to 
indicate that some participants indicated disability on the presence, severity and 
episodic scales for these domains. 
3.9.2 Construct analysis of the HDQ 
The Kaiser-Mayer-Olkin (KMO) test of sampling adequacy and the Bartlett’s tests 
of sphericity were used to confirm the data were adequate for a factor analysis. A 
principal component factor analysis with varimax rotation was used to confirm the 
a priori factor structure as found by O’Brien et al. (2014) for the domains on the 
HDQ using factor loadings. Eigen values were set at 1 and factor loadings were 
set at 0.30.  
A confirmatory factor analysis of the HDQ was published by O’Brien et al. (2014) 
using maximum likelihood analysis and Root Mean Square Error of Approximation 
(RMSEA).  The same parameters were used in a confirmatory factor analysis on 
the severity data of the HDQ for the sample in this study. 
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3.9.3 Convergent and divergent validity 
The scores on the WHODAS -2 which measures the same constructs of activity 
limitations and participation restrictions as the HDQ was correlated with the 
severity scores on the HDQ to determine convergent validity. The MOS-SSS 
which measures quality of life which has been shown previously to be a construct 
divergent to disability related activity limitations and participation restrictions was 
correlated with the HDQ to determine divergent validity. Spearman’s correlation 
coefficients were used as the scales are ordinal scales. The correlations were 
interpreted according to the following criteria (Tomita, Mann, Fraas, & Stanton, 
2004).  
 
 0 - 0.29 no correlation 
 0.30 – 0.39 A weak correlation 
 0.40 – 0.59 A moderate correlation 
 0.60 – 0.79 A strong correlation 
 0.80 – 1.00 Excellent 
3.9.4 Construct validity based on known group variables  
Construct validity was determined by comparing the known group variables for the 
participants against demographic and medical factors. The level of disability was 
determined on the HDQ severity score. A score of 0 was considered as no 
disability, a score of 1-24 was considered as mild disability, a score of 25-50 was 
considered as moderate disability and a score of 50+ was considered a severe 
disability. The frequency of the different levels of disability related to activity 
limitations and participation restrictions were calculated for the sample in this 
study.  
Based on the hypotheses the demographic and medical factors were analysed for 
each level of disability related to determine if there was any difference for these 
factors for the groups with no, mild, moderate or severe disability.  
 
3.9.5 Reliability 
Since the HDQ is a self-report questionnaire no interrater reliability needed to be 
established. The internal consistency was determined for the domain and total 
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scores with 0.70 being set as an adequate level of consistency (Tavakol & 
Dennick, 2011).  
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CHAPTER 4: RESULTS 
4.1 INTRODUCTION  
This chapter presents the results of the demographics of the participants as well 
as medical information related to HIV and analysis to determine the validity of the 
HDQ for the sample in this study. Psychometric properties of the HDQ, and also 
the validity and reliability of the HDQ was also reported in this chapter.  
4.2 DEMOGRAPHIC AND MEDICAL INFORMATION OF THE 
PARTICIPANTS 
Demographic information of the population of this study would be described to 
form a basis for the discussion of the population in this study. 
4.2.1 Age, gender and population group 
There was an unequal distribution according to gender with 158 (31.73%) of 
participants being males and 340 (68.27%) female (Figure 4.1).  
 
 
Figure 4.1 Gender distribution of participants (n=498) 
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Table 4.1 Indicates that the age of participants in the study was concentrated 
between 30 years old and 49 years old (72.89%) Age distribution showed that 
most of the participants (90.16%) were above 30 years. 
Table 4.1 Age and population group (n=498) 
 n (%) 
Age 
20-30 49 (89.87) 
30-39 198 (39.91) 
40-49 165 (33.26) 
50-59 69 (13.91) 
60+ 15 (3.02) 
Population group 
Black 474 (95.18) 
Indian 1 (0.2) 
Coloured 8 (1.61) 
White 15 (3.01) 
 
Analysis of race according to population grouping revealed that most of the 
participants were Black, while the smallest number were Indian (0.2%) with 
Coloureds and Whites making up the 3.01% and 1.61%of the sample respectively. 
 4.2.2 Martial status and children 
There were 240 single participants in this study accounting for 48.19% of the 
sample and 182 were married making up 36.55% of the sample. A divorced, 
widowed and separated status was also reported under the remaining 14.50% of 
the participants. Few participants (5.42%) had more than four children with 
majority of the study population having between one to four children 410 
(82.33%). Sixty one (12.25%) reported having no children.  
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Table 4.2 Martial Status and number of children (n-498) 
 n (%) 
Marital status 
Single 240 (48.19) 
Married 182 (36.55) 
Other status 70 (14.50) 
Children 
1-4 children 410 (82.33) 
More than 4 children 27 (5.42) 
No children 61 (12.25) 
 
4.2.3 Education, Employment and Disability grants 
For this study, the highest level of educational falls between participants with 
matric and some tertiary education (247, 49.60%). Those with Grade 11 and 
below including some participants with no education made up 42.97% of the 
sample. Lowest percentage of participants had (37, 7.43%) bachelors and other 
degrees (Table 4.3).  
Table 4.3 Education and Employment status (n=498) 
 n (%) 
Highest level of Education 
None to Grade 11 213 (42.97) 
Matric and some tertiary education 247 (49.60) 
Degree  37 (7.43) 
Employment status 
Employed 307 (61.65) 
Unemployed 191 (38.35) 
Disability grants 
No grant 479 (96.18) 
Receive a grant 19 (3.82) 
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Among this population, there are more patients (307, 61.65%) that are employed 
while unemployed participants accounted for 191 (38.35%) of the sample  
Disability grants were received by 19 (3.82%) of the participants (Table 3). 
4.3 MEDICAL INFORMATION 
4.3.1 WHO HIV stage, CD4 count and viral load 
Participants were divided into groups according to the World Health Organization 
Stage distribution for HIV. From Table 4.4 it is noted that 148 (65.49%) of the total 
study population have a WHO stage of 1 as indicated by the case file review.  
While 32(14.16%) have a WHO stage of 3, 29(12.83%) have a WHO stage of 2 
with a small percentage of participants 17 (7.52%) at WHO stage of 4. A number 
of patients 272 (54.6%) did not have this information in their files (Table 4.4).  
Table 4.4 World Health Organisation HIV stage, CD4 counts and viral load 
(n=498) 
 n% 
WHO Stage 
WHO Stage 1 148 (65.49%) 
WHO Stage 2 29 (12.83) 
WHO Stage 3 32 (14.16%) 
WHO Stage 4 17 (7.52%) 
CD4 Count 
< 200 cells/microliter 52 (10.44) 
201-349 cells/microlitre 137 (27.51) 
350-500 cells/microlitre 121 (24.30 
>500cells/microlitre 188 (37.75) 
Viral Load 
Undetectable viral load 231 (47.23) 
Detectable viral load 258 (52.76) 
 
A small percentage of participants (10.44%) presented with a CD4 count below 
200 cells/microlitre. Further analysis revealed that although 89.76% of the study 
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participants has a CD4 counts above 200 cells/microlitre, a similar percentage had  
a CD4 count between 201-349 cells/microlitre, and between 350-500 
cells/microlitre while just over a third (37.75%) had a CD4 count above 500 
cells/microlitre (Table 4.4). A greater percentage of female participants had higher 
CD4 counts than male participants. A similar finding was seen for the undetectable 
viral load which was found in a higher percentage of female participants (52.23%) 
when compared to the male participants (36.19%).  In the total group the 
percentage of participants with detectable and undetectable viral load was similar 
with slightly more participants (52.76%) having a detectable viral load. 
4.3.2 Concurrent Health Conditions 
The majority of the participants (70%) did not indicate any incidence of concurrent 
health conditions. The number of concurrent health conditions reported by each 
participant was important as the higher the number of concurrent health conditions 
may be related to their disability (O’Brien et al., 2008) and this is represented in 
Table 4.5.  
Table 4.5 incidence of concurrent health conditions in the participants 
(n=498) 
Number of Concurrent Health 
Conditions  
n (%) 
0 349 (70.0) 
1 99 (19.8) 
2 29 (5.8) 
3 12 (2.4) 
4 4 (0.8) 
5 3 (0.6) 
6 and 7 1 (0.2) 
 
The type of concurrent health conditions was aslo recorded and of the 149 (30%) 
participants who did report concurrent health conditions, the most common 
concurrent health conditions reported were hypertension (31.5%), Tuberculosis, 
muscle and joint pain and kidney infections and kidney failure (10.1%), 
headaches, flu and Castleman’s flu as well as diabetes (9.39%). Other concurrent 
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health conditions reported by between 5.6% and 3.36% of participants include 
pulmonary disease, Lipodystrophy, ulcers, diarrhoea and cancer. A very small 
number of participants (2.0%) reported debilitation conditions including loss of 
sight, hearing, stroke as well as depression as concurrent to their HIV diagnosis. 
4.3.3 Medication 
Figure 4.2 shows that majority of the study participants (52.01%) have been on 
ART for a period of more than 5 years, while 35.74% have been on ART for period 
ranging from 1 to 5 years. A small percentage (12.25%) has been on ART for a 
period ranging from 6 months to 1 year. 
 
  
Figure 4.2 Length of time participants have been taking antiretroviral 
medication (n=498) 
 
4.4 THE HIV DISABILITY QUESTIONNAIRE  
The results for the presence, severity and episodic nature scales for the 
participants were determined. The HDQ is divided into three scales which consider 
the presence of disability, the severity of disability and the episodic nature of 
disability as a percentage of the sample. For the HDQ, median scores were used  
as the data were not normally distributed and as was confirmed by the differences 
in the median and mean scores. Median scores also accommodated the ordinal 
0
10
20
30
40
50
60
More than 5 years Between one and five years 6 months to 1 year
p
e
rc
e
n
ta
ge
 p
ar
ti
ci
p
an
ts
 
55 
 
nature of the data. Means and SD were presented to accommodate median score 
of 0 in some domains indicating that mild disability was found for these domains in 
this study on the HDQ.   
 4.4.1 Scales of the HIV Disability Questionnaire   
4.4.1.1. Presence of Disability 
The median scores indicate that the presence of disability in the participants 
ranged between the different domains on the HDQ.  
Table 4.6 The scores for the domains and totals for presence of disability on 
the HIV Disability Questionnaire (n=498) 
Total group (n=498) 
Mean  
(SD) 
Median Lower 1st 
quartile - 
Upper 3rd 
Quartiles 
Difference in 
mean and 
median 
scores 
Total Score 
Presence 
28.99 
(22.86) 
24.63 10.14, 42.02 4.36 
Domain 1: Physical 
Symptoms 
26.99 (9.81) 28.01 18.87, 23.69 -1.02 
Domain 2: 
Cognitive 
Symptoms 
21.28 (8.40) 21.28 20.08, 28.18 0 
Domain 3: Mental 
and Emotional 
Health Symptoms 
28.11 (9.49) 27.71 18.87, 35.14 0.4 
Domain 4: 
Uncertainty 
44.85 
(11.18) 
44.67 39.15, 53.01 0.18 
Domain 5: 
Difficulties with day 
to day activities 
15.26 
(10.68) 
12.65 9.43, 9.07 2.61 
Domain 6: 
Challenges to 
taking part in Social 
and Community Life 
24.83(10.79) 20.28 16.46, 30.32 4.55 
 
The lowest score was obtained for Domain 5: difficulty with day to day activities 
indicating a low presence of disability in this domain and the highest score of 
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44.67 was for Domain 4: uncertainty. The score for all other domains were similar 
with a total presence score of 24.63. 
4.4.1.2 Severity of Disability 
Table 4.7 shows the severity of disability domain scores for the HDQ. As for 
presence Domain 4: Uncertainty had the highest median at 21.42. The median 
score for some domains were 0 for the severity reported by participants for 
Domain 2: cognitive symptoms and Domain 5: difficulty with day to day activities. 
The mean scores indicated the presence of mild severity in these two domains. 
The severity in other domains was reported as less than a score of 10 with the 
total severity score at 10.14. 
Table 4.7 The scores for the domains and totals for severity of disability on 
the HIV Disability Questionnaire (n=489) 
Total group (n=498) 
Mean  
(SD) 
Median Lower 1st 
quartile - 
Upper 3rd 
Quartiles 
Difference 
in mean 
and 
median 
scores 
Total Score Severity 14.72 (13.86) 10.14 4.34,20.66 4.58 
Domain 1: Physical 
Symptoms 
11.75 (11.97) 8.75 3.75, 16.25 
3 
Domain 2: Cognitive 
Symptoms 
8.40 (15.26) 0.00 0.00, 8.33 
8.4 
Domain 3: Mental and 
Emotional Health 
Symptoms 
14.23 (19.05) 6.81 0.00, 20.45 
7.42 
Domain 4: Uncertainty 27.19 (24.35) 21.42 7.14, 42.85 5.77 
Domain 5: Difficulties 
with day to day 
activities 
7.04 (13.10) 0.00 0.00, 8.33 
7.04 
Domain 6: Challenges 
to taking part in Social 
and Community Life 
12.81 (16.86) 6.25 0.00, 18.75 
6.56 
 
4.4.1.3 Episodic Nature of Disability 
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The median scores indicated that the episodic nature of disability in the 
participants occurred in all the domains on the HDQ. As for presence of disability 
the lowest score was obtained for Domain 5: difficulty with day to day activities 
indicating a low fluctuation day to day in this domain and the highest score of 
33.63 was for Domain 4: uncertainty. The score for all other domains were similar 
with a total presence score of 15.94. 
Table 4.8 The scores for the domains and totals for episodic nature of 
disability on the HIV Disability Questionnaire   
Total group (n=498) 
Mean  
(SD) 
Median Lower 1st 
quartile - 
Upper 3rd 
Quartiles 
Difference 
in mean 
and median 
scores 
Total Score Episodic  22.16 (21.64) 15.94 5.79, 26.10 6.22 
Domain 1: Physical 
Symptoms 
21.43 (7.10) 22.89 17.07,19.08 -1.46 
Domain 2: Cognitive 
Symptoms 
16.87 (2.21) 16.87 14.66, 27.11 0 
Domain 3: Mental and 
Emotional Health 
Symptoms 
22.42 (7.04) 22.29 15.69, 39.5 0.13 
Domain 4: Uncertainty 33.48 (8.77) 33.63 28.71, 39.56 -0.15 
Domain 5: Difficulties 
with day to day 
activities 
12.70 (5.36) 12.45 8.23, 16.06 0.25 
Domain 6: Challenges 
to taking part in Social 
and Community Life 
18.07 (7.16) 15.07 13.05, 21.89 3 
 
When question 70 on the HDQ was analysed 437 (87.7%) of participants reported 
the day on which they were assessed was a good day and only 12.3 % reported 
having a bad day. 
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4.5 VALIDITY AND RELIABILITY OF THE HIV DISABILITY 
QUESTIONNAIRE FOR A SOUTH AFRICAN SAMPLE 
The validity of the HDQ for the South African sample in this study was determined 
by completing a factor analysis on the data for the presence, severity and episodic 
disability scale results. More so, the convergent validity for disability related to 
activity limitations and participation restrictions and divergent validity to a quality of 
life measure was also reported. Reliability was assessed by determining internal 
consistency of the HDQ. 
4.5.1 Factor Analysis of the HIV Disability Questionnaire 
Before the principal component factor analysis and a pattern matrix were 
completed on the scores for the severity scale to establish the adequacy of the 
data factor analysis was determined using the HDQ severity scale. The score of 
Kaiser-Mayer-Olkin (KMO) test of the adequacy of the sample for the HDQ was 
0.93 which is at an acceptable level. Bartlett’s test of sphericity also reached 
significance of p≤0.001 which indicates the data were suitable for structure 
detection and should reveal distinct factors.   
The pattern matrix from a principal component factor analysis on the scores for the 
severity scale was completed with varimax rotation that indicated that the six 
domains or dimensions of the HDQ were perserved for four of the six domains  for 
the sample in this study. Most items loaded sufficiently (0.3) except item 19 
(hearing), item 64 (I find it hard to talk with others about my illness, even my family 
and friends), 67 (I find it hard to start new, intimate, sexual relationships living with 
HIV.), 68 (I tend to isolate myself from others because I am HIV positive).  
Six items from domain 5 (difficulties with day to day activities) loaded with Domain 
6 (challenges to taking part in social and community life). Three items under 
Domain 6 (challenges to taking part in social and community life) loaded under 
Domain 4 (uncertainty). The six domains all had Eigen values above one which 
account for 49.6% of the variance (Appendix I). 
Two approaches in a confirmatory factor analysis were used to determine the 
goodness of fit of the domain in HDQ for the sample in this study. All standardised 
factor loadings presented in red in Appendix I indicate that all items should be 
included in the model but the Chi-squared value for the confirmatory factor 
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analysis on the severity scores of the HDQ showed a significant difference in the 
fit between the patterns observed in the matrix and the domains specified (p≤ 
0.001). 
The goodness of fit of the domains described in the HDQ severity scale was 
further tested using RMSEA based on a maximum likelihood method of estimation 
suggested for assessment instruments with a large number of items but a small 
number of factors for data that is not normally distributed (Mislevy, 1986). Table 
4.9 indicates that the RMSEA estimate fell below 0.05 supporting an acceptable fit 
for the domains on the HDQ severity scale.   
Table 4.9 Results Confirmatory Factor Analysis – Goodness of Fit  
Chi-Square Statistic Steiger-Lind RMSEA 
Chi-Square Statistic: = 4314.57 Point Estimate:   0.042 
Degrees of Freedom: 2276 
p-value: ≤ 0.001 
 >Lower 90% Bound: 0.0406 
>Upper 90% Bound:  0.0444 
 
The factor analysis does indicate differences for some items in two of the domains 
on the HDQ for the South African sample with a number of items indicating that 
items previously under day to day activities fit better into social inclusion and 
uncertainly constructs.   
4.5.2 Convergent and Divergent Validity 
The HDQ results for severity of disability reflecting activity limitations and 
participation restrictions were correlated with the results on two reference 
measures namely the WHODAS2 and the MOS-SSS. 
4.5.2.1 Convergent Validity -World Health Organisation Disability 
Assessment Scale -2  
Table 4.10 shows the disabilities reported by participants in this study on the 
WHODAS 2.0. The difference in the mean and median scores indicates that the 
data were not normally distributed for this sample. Six of the domains had a 
median score of 0 but the mean indicated disability scores between 11.65 and 
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5.74 for these domains as some participants reported a problem in cognition, 
mobility, getting along with people and life activities.   
The total disability median score was 2.38 with median scores of 0 for all domains 
indicating no impairments and activity limitations which could be considered as the 
onset of disability (Hanass-Hancock, et al., 2015). A higher score was obtained for 
participation in society where disability median score of 4.17 was obtained (Table 
4.10).  
 
Table 4.10 Scores for the domains and total score on the World Health 
Organisation Disability Assessment scale -2 (n=498) 
Total group (n=498) 
Mean  
(SD) 
Median Lower 1st 
quartile - 
Upper 3rd 
Quartiles 
Difference 
in mean 
and median 
scores 
Total Score  9.97(15.66) 2.83 0.00, 12.20 7.14 
Domain 1: Cognition 10.16(17.33) 0.00 0.00,15.00 10.16 
Domain 2: Mobility 10.33(19.18) 0.00 0.00, 12.50 10.33 
Domain 3: Self care 5.74(16.48) 0.00 0.00, 16.47 5.74 
Domain 4: Getting 
Along with people 
11.65(19.34) 0.00 0.00, 16.67 11.65 
Domain 5A: Life 
Activities (Domestic) 
8.84(19.19) 0.00 0.00, 10.00 8.84 
Domain 5B: Life 
Activities 
(School/work) 
7.99(18.18) 0.00 0.00, 0.00 7.99 
Domain 6: 
Participation in 
society  
14.91(20.66) 4.17 0.00, 20.66 10.74 
 
Convergent validity of the HDQ was assessed with the WHODAS -2 as both tests 
purport to measure the same constructs related to impairments, activity limitations 
and participation restrictions.  Table 4.11 shows the correlations between the HDQ 
and WHODAS 2.0.  
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Table 4.11 Correlations between the domains of the HIV Disability 
Questionnaire and World Health Organisation Disability Assessment -2 
WHODAS-
2 
Domain 1: 
Cognition 
Domain 
2: 
Mobility 
Domain 
3: Self 
care 
Domain 
4: 
Getting 
Along 
Domain 
5A: Life 
Activities 
1 
Domain 
5B: Life 
Activities 
2 
Domain 6 
Participatio
n in society 
Total 
Score 
HDQ rho 
Domain 1: 
Physical 
Symptoms 
0.39* 0.41* 0.32* 0.41* 0.34* 0.33* 0.37* 0.44* 
Domain 2: 
Cognitive 
Symptoms 
0.48* 0.33* 0.29* 0.31* 0.31* 0.33* 0.32* 0.36* 
Domain 3: 
Mental and 
Emotional 
Health 
Symptoms 
0.41* 0.33* 0.31* 0.42* 0.34* 0.34* 0.45* 0.45* 
Domain 4: 
Uncertainty 
0.41* 0.32* 0.24* 0.44* 0.32* 0.32* 0.50* 0.48* 
Domain 5: 
Difficulties 
with day to 
day 
activities 
0.45* 0.43* 0.38* 0.39* 0.42* 0.41* 0.41* 0.45* 
Domain 6: 
Challenges 
to Social 
and 
community 
inclusion 
0.45* 0.38 0.32* 0.53* 0.40* 0.39* 0.56* 0.55* 
Total score 
for Disability 
Presence 
0.52* 0.46* 0.39* 0.55* 0.44* 0.42* 0.58* 0.60** 
Total Score 
for Disability 
Severity 
0.49* 0.42* 0.34* 0.51* 0.40* 0.39* 0.53* 0.56* 
Total score 
episodic 
disability 
0.36* 0.38* 0.26* 0.33* 0.36* 0.34* 0.37* 0.43* 
Significance  p≤ 0.05* 
p≤ 0.01** 
 
As hypothesised the total severity, presence and episodic scores of the HDQ have 
a moderate correlation with the WHODAS 2.0 total score.  
All the correlations were significant and all the domain scores of the HDQ with the 
exception of Domain 2 Cognitive symptoms also correlated moderately with the 
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total score of the WHODAS 2.0. There was a strong correlation between the total 
score of the WHODAS-2 and presence of disability on the HDQ. 
For the impairment domains, Domain 1 (physical symptoms) of the HDQ had a 
significant and moderate correlation (0.41) with the Domain 2 (mobility) on the 
WHODAS 2.0. Domain 2 (cognitive symptoms) on the HDQ had a moderate 
correlation (0.48) which was significant with Domain 1 (cognitive systems) of the 
WHODAS 2.0. These correlations were all significant at the p≤0.05 level but only 
those presented showed moderate positive correlations indicating scores that 
were high on the HDQ were also high for the WHODAS-2 and vice versa. 
One domain related to impairment Domain 3 of HDQ: mental and emotional health 
symptoms, and two domains related to activity limitations and participation 
restrictions Domain 4: uncertainty and Domain 6: challenges social and 
community inclusion, had a moderate correlation (0.45, 0.50; and 0.56 
respectively) with participation in society on the WHODAS 2.0. Domain 5 of the 
HDQ (difficulties with day to day activities) correlated significantly with Domain 5A 
(life activities 1) (0.42), Domain 5B (life activities 2) (0.41) and Domain 6: 
(participation restrictions) (0.41) of the WHODAS 2.0. The self care domain 3 on 
the WHODAS -2 had a low correlation with all scores on the HDQ. 
4.5.2.2 Medical Outcomes Study Social Support Survey 
Table 4.12 shows that participants in the study had a total score of 88.16 in social 
quality of life. Most scores were high indicating the little loss of QoL with domain 3 
(affection support) median score indicating no loss of QoL. The mean score 
however indicated some participants did have a lower QoL for this domain. The 
differences between the means and median scores indicate the data were not 
normally distributed. 
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Table 4.12 The scores for the domains and totals on the Medical Outcomes 
Study Social Support Survey (MOS-SSS) (n=489) 
 
Mean  
(SD) 
Median Lower 1st 
quartile - 
Upper 3rd 
Quartiles 
Difference in 
mean and 
median 
scores 
Total score 78.73 (24.18) 88.16 24.18,100.00 -9.43 
Domain 1: Emotional 
and informational 
support 
78.02 (24.96) 87.50 60.00,100.00 -9.48 
Domain 2: Tangible 
support 
75.73 (26.62) 80.00 55.00,100.00 -4.27 
Domain 3: Affection 
support 
82.32 (24.19) 100 66.66,100.00 -17.68 
Domain 4: Positive 
social interaction 
80.21 (25.29) 93.34 66.66,100.00 -13.13 
Question 14 25.92 (9.33) 33.33 20.00,33.33 2.61 
 
Divergent validity was confirmed by correlating the scores for the HDQ with those 
on the MOSS-SSS. It was hypothesised that these test measure two different 
constructs and no correlations would be found for the domains and total scores on 
the tests.  
While a small number of the correlations were significant at the p ≤0.05 level Table 
4.13 shows a negative weak correlation between all the scores for the HDQ and 
MOS-SSS for the domains and total scores for the two tests. This indicated these 
tests measure two different constructs and that the HDQ does not assess 
components of quality of life related to social support. 
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Table 4.13 Correlations between the domains of the HIV Disability 
Questionnaire and the Medical Outcomes Study Social Support Survey 
MOS-SSS Domain 1: 
Emotional 
and 
informatio
nal 
support 
Domain 2: 
Tangible 
support 
Domain 3: 
Affection 
support 
Domain 4: 
Positive 
social 
interaction 
Question 
14 
Total 
Score 
HDQ Rho  
Domain 1: 
Physical 
Symptoms 
-0.15 -0.13 -0.14 -0.15 -0.15 -0.15 
Domain 2: 
Cognitive 
Symptoms 
-0.17 -0.16 -0.19 -0.16 -0.17 -0.18 
Domain 3: Mental 
and Emotional 
Health Symptoms 
-0.27 -0.23 -0.26 -0.26 -0.25 -0.26 
Domain 4: 
Uncertainty 
-0.28* -0.24 -0.23 -0.23 -0.22 -0.26 
Domain 5: 
Difficulties with 
day to day 
activities 
-0.19 -0.15 -0.18 -0.17 -0.16 -0.19 
Domain 6: 
Challenges to 
Social and 
community 
inclusion 
-0.34* -0.30* -0.31* -0.33* -0.31* -0.33* 
Total score for 
Disability 
Presence 
-0.32* -0.29* -0.29* -0.29* -0.29* -0.04 
Total Score  for 
Disability Severity 
-0.29* -0.25 -0.26 -0.26 -0.25 -0.05 
Total score 
episodic disability 
-0.29* -0.15 -0.15 -0.14 -0.14 0.01 
Significance  p≤ 0.05* 
p≤ 0.01** 
 
4.6 LEVELS OF DISABILITY AND KNOWN GROUP VARIABLES  
The severity, presence and episodic nature of disability as assessed by the HDQ 
were considered for the participants in this study. Over half of the participants 
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presented with a mild disability both in levels severity (53.41%) presence (52.40%) 
and levels of episodic nature of disabilities (56.82%). A floor effect with 5% of 
participants reporting no presence of disability was found for the HDQ with no 
ceiling effect as no participant achieved a score of a 100 for presence or severity 
of disability. (Table 4.14) 
Table 4.14 Frequency table for Levels of severity, presence and episodic 
nature of disability  
 
Levels of 
severity of 
disability 
n (%) 
 
Levels of 
presence 
of disability 
n (%) 
 Levels of 
episodic 
nature of 
disability  
n (%) 
No 
disability 55 (11.04) No disability 23 (4.61) 
No change in 
last week 
55 (11,04) 
Mild 
disability 
266 (53.41) 
Mild disability 
in less than 
25% of items 
261 (52.40 
Change in last 
week in less 
than 25% of 
items 
283 (56.82) 
Moderate 
disability 114 (22.89) 
Moderate 
disability in 
less than 
50% of items 
135 (27.10) 
Change in last 
week in less 
than 50% of 
items 
104 (20.88) 
Severe 
disability 63 (12.65) 
Severe 
disability in 
more than 
50% of items 
79 (15.86 
Change in last 
week in more 
than 50% of 
items 
56 (11.24) 
 
All the known group demographic and medical variables assessed on the 
participants were compared to the severity and presence of disability as measured 
by the HDQ. The level of disability where the known group medical variables or 
the demographic variables differed significantly as hypothesised in Chapter 1 will 
be presented in this section. 
4.6.1. Severity of Disability  
4.6.1.1 Number of concurrent Health Conditions 
The number of concurrent health conditions the participants reported differed 
significantly depending on the severity of their level of disability (Figure 4.4). A 
large percentage (22.22%) of those with four to seven concurrent health 
conditions reports having severe disability as oppose 2.01% of those with no 
concurrent health condition. 
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Figure 4.4 Comparison of the percentage of number of concurrent health 
conditions reported by participants according to the severity of their level of 
disability (p=0.027) 
 
More so, 4.49% of those with no concurrent health condition also indicated no 
disability while none of those with 4-7 concurrent health condition report any 
disability. Figure 4.4 indicates that as the number of concurrent health conditions 
increased significantly so did the percentage of participants with a moderate and 
severe disability (p=0.027).  
4.6.1.1 Employment 
Figure 4.5 indicates there was a significant difference (p=0.019) in the percentage 
of participants employed when the severity of disability was considered with 80% 
percent of the participants experiencing severe disability been unemployed. A 
higher percentage of the unemployment was also found for those with moderate 
disability (19.9% vs. 13.7%).  
Figure 4.5 clearly indicates the effect of the severity of disability on employment as 
assessed by the HDQ. 
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Figure 4.5 Percentage employed and unemployed participants according to 
the severity of their level of disability (p=0.019) 
 
4.6.2 Presence of disability 
4.6.2.1 Age 
The presence of disability was significantly affected by age (p=0.049) as none 
(0.00%) of people between the ages of 50-59 experienced no disability and almost 
19% of those experiencing severe disabilities fall into this group as opposed to 
younger participant (20-30 years) where just 10% present with severe disabilities 
(Table 4.17).  
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Figure 4.6 Comparison of the older and younger participants according to 
the level of presence of disability (p=0.049).  
 
Although the difference across age groups differed with a smaller percentage of 
the older age group (40 to 60+ years) having disability in between 25-50% of items 
Figure 4.5 indicates the higher percentage of this older age group has a higher 
presence of disability.  
4.6.3 Length of time on antiretroviral therapy 
A significant difference (p=0.003) was revealed between the length of time 
participants have been on medications and level of disability presence (Table 
4.18).  
Majority (59.49%) of the participants experiencing severe disability have been on 
medication for more than 5 years only 3.9% of the people who have been on 
medication for more than 5 years also indicate no presence of disability in all 
domains of the HDQ. 
Figure 4.6 indicates the increase in the presence of disability in more than for 
participants that have been on ART for more than 5 years. 
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Figure 4.7 Percentage of participants according to the presence of disability 
and the length of time they having been taking antiretroviral medication 
(p=0.003). 
 
4.6.2.3 Employment status in relation to presence of disability 
A significant difference (p=0.002) was observed between employment and 
disability presence. This is illustrated in figure 4.8 below as 73.9% of the 
participants experiencing no disability are employed as compared to 26.07% for 
the unemployed. A higher percentage (56.96%) of those experiencing severe 
disabilities also reported being unemployed. 
 
Figure 4.7 indicates clearly that the level of the presence of disability as assessed 
by the HDQ was significantly different for the participants that were employed and 
unemployed.  
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Figure 4.8 Comparison of the percentage employed and unemployed 
participants according to the presence of disability (p=0.002) 
 
The hypotheses that the level of the severity and presence of disability would 
differ significantly for the known group variables of age, concurrent health 
conditions, length of time on ART and employment were accepted for this study. 
These findings support the construct validity of the HDQ in identifying different 
levels of disability in terms of other known group variables specifically associated 
with HIV. 
4.7 RELIABILITY OF THE HIV DISABILITY QUESTIONNAIRE 
(HDQ)  
The internal consistency of the domains on the HDQ was assessed. It was found 
that for the sample of participants in this study that the consistency of the scores 
was high above the acceptable level of 0.70 (Table 20).  
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Table 4.20 Cronbach’s Alpha scores for the HIV Disability Questionnaire 
(n=498) 
HDQ score HDQ 
severity 
score 
HDQ 
episodic 
score 
HDQ 
presence 
score 
Items(n) 
 Cronbach’s alpha  
Physical 
0.93 0.87 0.83 20 
Cognitive 0.93 0.88 0.85 3 
Mental-Emotional 0.92 0.85 0.79 11 
Uncertainty 0.93 0.87 0.79 14 
Difficulty with day-to-
day activities 
0.93 0.86 0.77 9 
Challenges to social 
inclusion 
0.93 0.87 0.81 12 
HDQ total (all items) 0.92 69 
 
4.8 SUMMARY OF RESULTS  
The aim of this study was to determine the validity (convergent and divergent) and 
internal consistent reliability of the HDQ. The construct validity of the HDQ was 
determined through confirmatory factor analysis. For the confirmatory factor 
analysis, goodness of fit was shown through Steiger-Lind RMSEA statistics which 
indicated that all items assessed one construct, disability.  
The convergent validity was confirmed by the moderate correlation of the a priori 
hypotheses between the HDQ and the WHODAS 2.0 while divergent validity was 
confirmed by 100 percent lack of correlation between the total severity score of the 
HDQ and its domains and the MOS-SSS. Known group hypothesis was also 
developed and supported by the results as level and presence of disability differ 
significantly for age, concurrent health conditions, length of time on ART and 
employment.   
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CHAPTER 5: DISCUSSION 
5.1 INTRODUCTION 
This chapter presents an overview of the study’s findings for each objective in 
three parts. The first part discusses the demographic and medical factors of the 
participants of the study. The second part of this chapter explores the validity and 
reliability of the HIV disability questionnaire, while the third part discusses activity 
limitations, participation restrictions and social support in a sample of PLWHIV in 
Johannesburg Metro. Potential areas of study to be pursued beyond this study 
were also discussed. 
5.2 RESPONSE RATE 
A research population of 1436 participants who are adults and attending an HIV 
clinic in Johannesburg Metro area were approached. Only 502 gave consent to 
participate in this study giving a response rate of 35.9%. Of these participants, four 
HDQ were declared invalid because they did not meet the inclusion criteria and 
also because more than 10% of the information was missing.  
The response rate of this study was lower than the response rate of similar studies 
by Myezwa et al, (2009). Both of these studies were carried out in South Africa. 
One possible reason may be due to research fatigue on the part of the participants 
as most of them reported filling the WHODAS 2.0 before. Three of the four study 
sites are in University of Witwatersrand teaching hospitals, which are regular 
centres for different forms of research and sites for data collection.  
More so, respondent burden, convenience and length of time required to complete 
the questionnaire are some other factors that contribute to this low response rate 
as literature suggest that people are less likely to agree to take part in a survey 
that is longer because of the increased inconvenience (Collins et al., 1988). This 
was evident as many participants who didn’t take part in the study gave this 
reason. Lack of cash incentives in this study is another contributing factor to this 
low response rate, many studies report offering participants material incentives for 
participating increases response rate (Singer et al., 2000). This was particularly 
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true at Chris Hani Baragwanath Hospital where cash incentives were being 
requested by participants as previous studies had offered such incentives. This 
was supported by Singer et al. (1999) who reported that cash incentives have 
been more effective than any other types of incentives.  
5.3 DEMOGRAPHICS AND MEDICAL INFORMATION 
Basic demographic characteristics included in the study were age, sex, marital 
status, race and the number of children they have. Socioeconomic information 
recorded includes their highest level of education, current employment, and 
disability grant information. Some clinical outcomes were also recorded during the 
data collection, which included CD4 counts, viral load information and date of 
initiation of ART. 
5.3.1 Demographics 
The mean age of the study participants was 41 years with the majority of 
participants between 30 and 49 years (Table 4.1). This was similar to the mean 
age reported in another disability study with PLWHIV on ART in South Africa with 
mean 38 years. These results reflected those reported by the Human Sciences 
Research Council (HSRC) in their HIV prevalence survey (Shisana, et al., 2014).  
The proportion of female participants in this study was 68.27% (Figure 4.1)  which 
is similar to other studies in South Africa and other African countries where 
percentage of female to males with HIV is approximately two-thirds to one-third. 
This concurs with HIV statistics for South Africa and is supported by studies in 
which the percentage of females ranges from 60.3% to 79% (Chetty & Hanass-
Hancock, 2016; Hanass-Hancock, et al., 2015; Mugisha, et al., 2016; Narsai, et 
al., 2016). Therefore it can be accepted that the age and gender distributions in 
this study are reflective of the trends for PLWHIV in South Africa.  
The distribution of race for the participants in this study was congruent with the 
prevalence reported by the HSRC for PLHIV exposed to ART, according to 
population group, ninety-five percent of participants were Black with 5% of 
participants from the Indian, Coloured and White population groups which is 
similar to the 4% reported by the HSRC (Shisana, et al., 2014).  
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The majority of participants were single (Table 4.2) and approximately 20% more 
male than female participants were married. Being married has been associated 
with lower incidence of HIV infection for males. This was supported by the HSRC 
survey where relationship between marital status and HIV incidence was lowest at 
0.6% compared to single individuals who had more than one sexual partner in a 
year where the incidence was 2.4% (Shisana, Risher, Celentano, Zungu, Rehle, et 
al 2016). In a study by Pitpitan, Kalichman, Eaton, Sikkema, Watt, et al. (2016) on 
men’s behaviours being a predictor for women’s risk for HIV/AIDS, they reported 
that only 27.1% of participants participating in drinking and unprotected sex were 
married. This supports the findings that single individuals are more are at risk for 
HIV infection (Pitpitan et al., 2016).  
A high proportion of the participants (82.33%) have between one and four children 
with 85% of the female participants having children. Some participants are single 
parents as a high percentage of participants who have children indicated they 
were single. 
More than half of the study participants have matric and some tertiary education. 
Although not supported by this study, knowledge about the prevention of HIV has 
been found to be significantly better in participants with a higher level of education 
(matric to some tertiary education) when compared with those without any formal 
education. This may explain the lower proportion (7.4%) of the participants with 
degree in this study. Another explanation for this low prevalence in people with a 
degree is because this group may be able to afford private health care thus could 
be treated elsewhere.  
Hargreaves, Morison, Chege, Rutenburg, Kahindo, et al. (2015) found discernible 
trends or correlations between education, socioeconomic status and HIV 
prevalence in young individuals and HIV prevalence in South Africa and Eastern 
Africa (Hargreaves, et al., 2015). Those from lower socioeconomic circumstances 
are more likely to take part in risky sexual behaviour and are less likely to be 
tested and present with a higher prevalence of HIV (Wabiri & Taffa, 2013).  
Two-thirds of the participants in this study were either employed (full-time or part-
time) or attending school. More participants in this study reported being employed 
than the 49% reported in a similar study on disability in PLWHIV on ART by 
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Hanass-Hancock, et al. in 2015 (Hanass-Hancock, et al., 2015). The employment 
rate reflected that for Gauteng province in 2016 however (Statistics SA, 2016). 
With 57.03% of the study participants having a level of education above matric, it 
can be assumed that most of the participants have some insight and knowledge 
about HIV as well as having access to treatment.  This raises the question 
whether this sample is biased as it does not include those who are not being 
tested and accessing treatment for HIV since only 48% of PLWHIV in South Africa 
are accessing ART (UNAID, 2016). It is not clear whether this missing population 
is more poorly educated, have a lower socioeconomic status and have less 
access to health care.  
Contrary to the findings of Govender et al. (2015) none of the participants in this 
study were receiving disability grants, although 10.44% of the participants in this 
study qualified for these grants as they had a CD4 of <200 cells/microlitre. 
Knowing the threshold level of the participants income would have better 
explained if any participants,  even with CD4 count <200 cells/microlitre qualified 
for a temporary disability grant. Govender et al. (2015) reported that people living 
with HIV deliberately refuse to adhere to ART to lower their CD4 count so they can 
have access to disability grants. Nearly 90% of participants in this study had CD4 
counts higher than 200 cells/microlitre, indicating they might have been more 
aware of the side effects of non-adherence to their HIV medications than requiring 
state assistance in the form of a small disability grant although this needs further 
investigation. (Govender et al.,2015).  
This finding may have been affected by the relatively high employment rate found 
for study with the 3.8% of study participants receiving permanent disability grants 
being similar to that reported by Hanass-Hancock, et al.(2015), Those receiving 
grants had been diagnosed with other  permanent disability such as blindness.  
5.3.2 Medical Information 
Clinical outcomes such as length of time participants have been on ART and 
occurrence of opportunistic infections are important indicators of disease 
progression and response to treatment. plasma HIV-1 viral load, WHO clinical 
stage, and CD4 counts are some of the important indicators for monitoring and 
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evaluating the prognosis of HIV and the possibility of developing disabilities in 
people living with HIV. 
More than 50% of the participants WHO stages were missing in the case files and 
this information could not be inferred from the CD4 count or viral load as the HIV 
clinical staging was based on clinical finding and diagnosis and no other medical 
information. For those participants where the WHO stage was indicated the 
majority (65.5%) were in stage 1 which indicated that they are asymptomatic for 
concurrent health conditions (World Health Organisation, 2007). 
The CD4 counts staging use in this study was based on the WHO 
immunosuppression staging of disease. The proportion of the participants with 
CD4 counts higher than 200cell/microlitre was very high (89.6%) which is similar 
to results from other studies in South Africa (Centres for Disease Control and 
Prevention, 1999). 
It has been physiologically shown that females, either HIV negative or positive, 
have a higher CD4+ T-lymphocyte (CD4) count compared to males  (vom Steeg & 
Klein, 2016) . Small but significant, this study showed a higher CD4 count for 
females than males. A study by Maskew, Brennan, Westreich, McNamara, 
MacPhail &, Fox. (2013) at the Themba Lethu Clinic where some data for this 
study was collected, confirmed the gender differences in the CD4 count. They 
attribute this to men only accessing treatment at a later stage in disease with lower 
CD4 counts (Maskew et al., 2013).  
In this study, about half (47.2%) (Table 4.4) of the participants had an 
undetectable viral load with females having a higher (52.2%) undetectable viral 
load. These results are similar to those in other studies in South Africa and better 
than those reported for other African countries where access to ART is limited 
(Tun, et al., 2016). The higher percentage of females with undetectable viral load 
and higher CD4 counts is congruent with studies in sub-Saharan Africa due to 
reduced adherence in men (El-Khatib, Katzenstein, Marrone, Laher, Mohapi et al., 
2011) with men generally having a higher risk of viral infection (Kipp, Alibhai, 
Saunders, Senthilselvan, Kaler, et al 2010). 
The undetectable viral load for the participants in this study was lower than the 
nearly 90% of participants reported with undetectable viral load in relation to the 
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validation and use of the HDQ in developed countries. This may be explained by 
the late provision of ART to the participants in this study. Most participants would 
only have been started on ART when they had a CD4 < 200 cells/microlitre as this 
was the policy of the Department of Health prior to 2016. Research indicates that 
patients who start ART at this stage may not achieve adequate CD4 counts or 
undetectable viral load over a five year period and are more likely to be 
compromised in terms of their health (Ferrer, Curto, Esteve, Miro, Tural, et al., 
2015). 
In this study, participants reported 48 different concurrent health conditions with 
30% reporting having one or more condition. This was less than the 40% reported 
by Hanass-Hancock et al. (2015) in their study of PLWHIV on ART in South Africa 
(Hanass-Hancock, et al., 2015). Opportunistic infections occur commonly in 
patients with HIV/AIDS due to lowered immune responses. However, the study 
found that 20.68% of the HIV/AIDS patients have one type of opportunistic 
infection while 4.7% experience two types; it was observed that the majority of the 
HIV/AIDS patients do not experience any opportunistic infections (73.98%). This 
may be due to the fact that the participants in this study are attending a clinic and 
have access to ART. They have also been taking ART for a relatively short time 
compared to those in studies on validity of the HDQ in developed countries 
(O’Brien et al., 2015). High blood pressure was the most reported concurrent 
health condition by about a quarter of the participants which was similar to that 
report by Canadian participants living with HIV, assessed for disability on the HDQ 
(O’Brien et al., 2015). The percentage of participants who reported other health 
conditions was much lower than reported in Canada and Ireland in the validity and 
reliability study of the HDQ (O’Brien et al., 2015). Tuberculosis which has reached 
epidemic proportions in relation to HIV infection in South Africa was reported by 
just fewer than 10% of participants. This is congruent with the drop in TB rates in 
PLWHIV on ART and the increased cure rate reported in South Africa from 2011 
(World Health Organisation, 2013). 
Half of the study participants (52.0%) have been on ART for a period more than 5 
years which reflects the roll out of ART in South Africa between 2004 and 2011 
(World Health Organisation, 2013). There were only a small percentage of 
participants (12.3%) who have been on ART for a period less than a year 
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reflecting the lower incidence 1.22 of new infections in the age group assessed for 
this study (Table 2.1) (Stats SA, 2015).  
 5.4 VALIDITY AND RELIABILITY OF THE HIV DISABILITY 
QUESTIONNAIRE  
The aim of this study was to investigate the validity of the HDQ in PLWHIV in a 
developing country. In line with validity studies previously completed on the HDQ, 
a factor analysis, concurrent validity for the severity of disability and divergent 
validity in terms of quality of life were established. The internal consistency of the 
three scales on the HDQ was determined. 
5.4.1 Factor analysis 
Factor analysis was used to determine the fit of the data assessed in the South 
African sample to the hypothesised domains of disability measured by the HDQ. 
On rotated principal extraction of factors, the impairment domains for physical 
symptoms, cognitive symptoms and mental and emotional symptoms all loaded on 
the a priori factors as expected. On Domain 4: uncertainty, all expected items 
loaded as well as three items under challenges of social and community inclusion 
which also loaded in this factor. These items relate to social isolation and deal with 
aspects of discussion about the condition with family and friends as well as 
starting new sexual relationships. It is not clear why in this sample these items 
should load into the uncertainty domains as they appear to deal with social 
inclusion. This aspect would need further investigation.  
In Domain 5: difficulties with day to day activities, the activities related to 
occupational performance areas such as personal and instrumental activities of 
daily living and leisure appear to load with other instrumental activities of daily 
living, work and social activities in Domain 6: challenges with social and 
community inclusion. For this study it appears that the inability to complete 
grooming, leisure, household chores, use transport and manage finaces do load 
with care of others, work activities and social activites, indicating that these 
occupational performance skills load with social and community participation. 
There is therefore no clear differentiation for these items which could be 
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considered activity limitations on the HDQ from participant restrictions for the 
sample in this study. 
These results may be due to differences in the sample used for this study which 
differed in age, length of time on ART, gender distribution and employment status 
when compared to that reported in the Canadian study (O’Brien et al in 2014), 
Participants in this study may have seen personal and instrumental activities of 
daily living as important in supporting their ability to work and integrate socially.  
These aspects should be investigated further in validating the HDQ for developing 
counties and according to various known group variables. 
Overall in the confirmatory factor analysis and the maximum likelihood method 
indicated that the all items load under 6 factors indicating the HDQ measures had 
a single construct of disability. The other results for the goodness of fit reflect 
those reported by O’Brien et al in 2014. The lack of fit as indicated by the 
significant result for the chi-squared test, in this case, can also be over inflated by 
the large sample size as in the study by O’Brien et al (2014) is not as important as 
the significant RMSEA results, which in this case, showed an acceptable fit as did 
the fit for each item (O’Brien et al 2014). Thus the model with six domains was 
accepted as valid for the South African sample (Table.4.14) as the relationships 
between 6 domains in the HDQ was still similar although the items in the domains 
would need to be reviewed and investigated further for different populations.  
5.4.2 Convergent and divergent validity 
Convergent validity of the HDQ was tested by correlating it with the WHODAS 2.0 
and divergence was tested with the MOS-SSS which considers the quality of life 
related to social support which was not the intention of the HDQ. 
The four convergent validity correlation hypotheses were supported by the South 
African participants. The first hypothesis that the total severity, presence and 
episodic nature of disability scores, as well as all the domain scores of the HDQ, 
will correlate moderately with the total score of the WHODAS 2.0 was supported 
with moderate to strong positive correlations which were significant at p≤0.05. This 
hypothesis was developed based on the fact that the two disability assessment 
tools was developed to measure impairments, activity limitations and participation 
restrictions in related domains of disability. The WHODAS 2 has previously been 
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used to assess disability in PLWHIV in South Africa in a diverse sample and was 
found to identify activity limitations and participation restrictions in 49.9% of 
PLWHIV (Hanass-Hancock, et al., 2015). The median scores of 0 obtained 
indicate that over 50% of the participants in this study also reported no activity 
limitations and participation restrictions for most domains on the WHODAS 2 in 
agreement with this finding (Table 4.10). Hanass-Hancock, et al. (2015) also 
indicated that 35% of their participants scored 3 or 4 on items on the WHODAS-2 
were considered as severe enough to indicate the onset of disability, with a 
slightly greater percentage of participants in this study (43%) scoring 3 or 4 on 
items on the HDQ which could be considered as onset of moderate or severe 
disability by (Table 11).  
The only exception for this hypothesis was for Domain 2: cognition symptoms 
score of the HDQ which however, had a weak correlation with the total WHODAS 
2 score. This may reflect the small number of items (3) in this domain on the HDQ 
as compared to the 6 in the WHODAS 2.  
The second hypothesis that Domain 2: cognition symptoms on the HDQ would 
correlate moderately with the equivalent impairment domain for cognition on the 
WHODAS 2.0 was accepted. A similar finding for physical symptoms of the HDQ 
and mobility on the WHODAS 2 indicate these domains consider similar 
constructs and can be considered valid for the HDQ. The third symptom domain 
on the HDQ for mental and emotional impairment is not reflected as a separate 
domain on the WHODAS 2 but did correlate moderately with the domain for 
cognition on the WHODAS 2.0. This correlation was supported by Hanass-
Hancock et al.(2015) in their study in South Africa where they found a correlation 
between depression and cognition in PLWHIV (Hanass-Hancock, et al., 2015).  
The domains on the HDQ representing participation restrictions in the form of 
challenges to social and community inclusion, as proposed in the third hypothesis 
had positive moderate correlations above 0.5 with Domain 6: participation in 
society on the WHODAS 2.0. This indicates that the HDQ was measuring 
participation in society similar to that assessed by the WHODAS-2. 
A fourth hypothesis that the domain of social and community inclusion on the HDQ 
and getting along with others on the WHODAS 2 would be moderately convergent 
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was proposed as both contain similar items involving but not limited to how much 
participants has been emotionally affected by their health condition, how much 
they spent on their health condition and how much of a problem they have in 
joining community services. This hypothesis was accepted (Table 4.11).  
Similar moderate correlations for Domain 6: participation in society as well as 
Domain 4: getting along with people, on the WHODAS 2.0 were found for  Domain 
4: Uncertainty on the HDQ. Although uncertainty is a unique construct assessed 
on the HDQ with no corresponding domain on the WHODAS 2.0, the definition of 
uncertainty indicated it does have components related to emotion and social 
inclusion (Brashers, et al., 1999). Hanass-Hancock, et al. (2015) also found 
components related to emotion and social inclusion were related to participation 
restrictions in PLWHIV (Hanass-Hancock, et al., 2015).  
All of the domains on the HDQ had a weak correlation with the self-care domain 
on the WHODAS 2 as no domain on the HDQ considers personal activities of daily 
living exclusively but rather difficulty in day to day activities which correlated 
moderately with Domain 5: Life Activities on the WHODAS-2. These domains 
appear to cover activity limitations but they also correlate moderately with the 
domains indicating participation restrictions thus indicating a link between these 
two constructs in both assessments.  
Divergence from quality of life social support constructs was hypothesised, and 
the total domain scores of the HDQ did have weak negative correlations with the 
MOS-SSS scores (Table 4.13). This hypothesis was accepted proving the 
constructs assessed by these assessment instruments differ. The MOS-SSS like 
the WHODAS was developed for use with people living with a chronic health 
condition but not specifically developed for PLWHIV.  The MOS-SSS evaluates 
coping by looking for and getting help from others for emotional support for the 
adverse effects of chronic illness which is a different construct to disability in 
chronic illness.  
These results were similar to those reported by O’Brien et al (2015) in their study 
on the psychometric properties and the construct validity of the HDQ. The 
convergent and divergent validity of the HDQ reported by O’Brien et al (2014) 
were confirmed for the sample in this study indicating the HDQ does therefore, 
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assess disability as defined by O’Brien et al. (2008) when compared to reference 
measures.  
5.4.3 Known Group Hypotheses 
The known group hypotheses proposed for this study were based on those 
proposed by O’Brien et al. (2015) that disability in PLWHIV is related to age and 
concurrent health conditions. Two further hypotheses based on known group 
variables that differed significantly between the participants assessed by O’Brien 
et al. (2015) in their studies in Canada and Ireland were employment status and 
length of time on ART. These hypotheses were tested and were supported by this 
study in the South African population. Although comparing the known group 
variables for the South African sample with those reported for the Canadian and 
Irish study it was clear that lower median scores were obtained for the length of 
time on ART and the number of concurrent health conditions. While the average 
age of the participants was similar to that for the participants in Ireland and 
younger than those in Canada, more to the participants in South Africa were 
employed. In discussing the known group variables reference will be made to the 
previous validity studies for the HDQ in Canada and Ireland. 
5.4.3.1 Age, concurrent health conditions and length of time on antiretroviral 
The concept of physical symptoms and impairments is particularly relevant to 
aging with HIV, whereby older adults tend to have been living with the disease for 
a longer time thereby developing more comorbidities. The levels of disability were 
analysed according to the scores on the domains with those scoring 50 or more 
considered as having moderate to severe disability. The result of this study reveal 
that the majority of older participants experience mild to severe disability, a result 
similar to that revealed by Guaraldi Prakash, Moecklinghoff & Stellbrink., 2014 
who stated that chronic inflammations, frailty and increased morbidity is related to 
aging due to decline in ability of the body tissue to renew and repair themselves. 
This process is accelerated in HIV positive individuals resulting in high level of 
disabilities in this population (Guaraldi et al., 2014). 
Based on the known group factors O’Brien et al. (2015)  had already found a 
significantly higher level of disability on all the scales for all domains, and the three 
total scores between the older participants in Canada and those in Ireland. The 
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age of  participants in this study was similar to that reported for Ireland. The lower 
scores for all domains and total scores for the presence of disability found in the 
South African sample does not appear to be related strongly to age under 50 
years which supports the study by Guaraldi et al. (2014). They revealed a higher 
rate of concurrent health conditions in older participants with  the newly calculated 
life expectancy of 75 years in the HIV-positive men who have sex with men living 
in a developed country. This results in them experiencing higher levels of 
concurrent health conditions which includes, but is not limited to headaches, 
fatigue, diarrhoea, fever, and shortness of breath. 
This concept is supported by this study where the majority of the participants is 
98.84%, are over 50 years of age and have experienced some form of disability 
ranging from mild, moderate to severe in relation to the number of reported 
concurrent health conditions. This result can be accepted as a true picture of HIV 
in people above the age of 50 years. 
It is likely that concurrent health conditions play a larger role in the presence of 
disability as there was a significant difference between this variable reported by 
participants in this study. This is also reflected in the study by O’Brien et al. (2015) 
where participants in Canada with significantly higher scores for the presence of 
disability also had significantly more concurrent health conditions.  
An increase in the levels of severity of disability in this study was found for the 
length of time participants had been receiving ART. Participants who had been on 
ART for longer had more severe disability. This finding was supported by the lower 
levels of severity for all domains on the HDQ found for the South African sample 
when compared to the results from Canada and Ireland. This is the known group 
variables that differ from the previous studies using the HDQ. In Canada, the 
median year of diagnosis was 1999 with approximately 40% being diagnosed 
before 1996. In Ireland, the median year of diagnosis was 2003 and although not 
reported the participants in these cohorts have probably been on ART for much 
longer than the participants in this study. 
The participants assessed by the HDQ in Ireland with the significantly lower 
severity of disability had received ART for an average of 7 years. Based on the roll 
out of ART in South Africa which started in 2004, 80% reached clinics and those in 
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need with a resultant increase in life expectancy between 2009 and 2011. Thus 
the participants in the South African sample can be assumed to have received 
ART for a shorter period of mostly seven to eight years  (Johnson, 2012; World 
Health Organisation, 2013). 
5.4.3.2 Employment 
The HDQ was developed to assess disability in PLWHIV who were no longer 
employed. The results of this study indicated a significant difference in the level of 
the presence and severity of disability as assessed by the HDQ and the 
employment status of the participants. Those with more severe disability are 
significantly less likely to be employed. This is supported by Elzi, Conen, Patzen, 
Fehr, Cavassini, Calmy et al. (2016) in their study on Ability to Work and 
Employment Rates in (HIV)-1-Infected Individuals Receiving Combination 
Antiretroviral Therapy. This study revealed that employment rate increased by 
46.4% after a year of antiretroviral treatment among 947 individuals unable to 
work at baseline, thus indicating exposure to ART reduces the severity of disability 
and increases employment rate accordingly (Elzi et al., 2016).  
This study demonstrated that a population-based sample of people living with HIV 
in South Africa has been experiencing lower levels of disability than reported for 
samples in developed counties (O'Brien, et al., 2014). The majority of participants 
(80.3%) in this study experienced mild disability. This is similar to results by 
(Rusch et al., 2004) where they reported some activity limitations in 80.6% of their 
study participants 
The results for the participants in this study were similar to those reported by 
O’Brien et al. (2015) in that uncertainty scored as being the most common 
disability as well as being the most severe disability. This confirms the importance 
of including this construct in the HDQ in the assessment of disability in PLWHIV 
(O’Brien et al., 2015). The concept of uncertainty is particularly relevant to 
unemployment and financial uncertainty, aging with HIV, whereby older adults 
may worry about their source of health challenges transition to retirement or job 
security living with HIV health providers’ knowledge and skills; appropriate long-
term housing and who will care for them as they age living with HIV (Solomon, 
O'Brien, Wilkins & Gervais, 2014).  
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5.4.3.3 The presence, severity and episodic nature of disability 
Based on the Episodic Framework described by O’Brien et al (2015) the presence, 
severity and episodic nature of disability in the South African sample was 
considered. The HDQ was initially developed to test older PLWHIV who had more 
severe disability; therefore, for some items and domains for the sample in this 
study median scores of 0 were obtained, indicating no disability as the participants 
were younger and had milder disability which may have had an effect on the 
validity of the HDQ . This indicates the HDQ may not discriminate ability in a 
sample with demographic and medical factors representative of PLWHIV in 
developing countries.  
The presence of disability for physical, cognitive, mental and emotional health 
symptoms all scored at a similar level. In comparison, the studies in Ireland where 
more disability was reported for mental and emotional health symptoms. The 
lowest score was for difficulties with day to day activities for this study and was 
also reflected in the lowest score in the Canadian and Irish studies. This indicates 
similarity in the domains where disability is likely to be found in PLWHIV, 
confirming the HDQ reflects similar proportions for of the presence of disability in 
the various domains for the sample in this study. The one domain, mental and 
emotional health symptoms which exhibited presence of no disability in this study, 
differed when compared to the Canadian study where this domain reached a 
median of 100. This finding confirms the ability of the HDQ to differentiate between 
groups which were not comparible in terms of employment status, concurrent 
health conditions and lenth of time on ART. The finding may have also been 
influenced by the small number of items in this domain which did not identify 
mental and emotional symptoms in the sample in this study. This is troublesome 
as Hanass-Hancock et al. (2016) found this aspect to be of great concern in 
PLWHIV in their study in terms of disability (Hanass-Hancock et al., 2016). These 
aspects may not be adequately assessed by the HDQ and need further 
investigation. 
There was one marked difference for the HDQ in the South African sample. Higher 
episodic scores with the exception of physical symptoms was reported by the 
participants in this study than those reported by O’Brien et al., (2015) in the 
Canadian and Irish studies. People live more with uncertainty in low resourced 
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countries even if not HIV positive and this may impact more on those living with 
HIV. Participants may have reported more fluctuation in all aspects of their lives, 
more frequent bad days or changes in past week in all health challenges on the 
HDQ than participants in other studies because of less access to resources 
(Hanass-Hancock, 2009).  
This may be experienced under uncertainty in terms of concern about health due 
to aspects like accessing health care. It has been revealed that poor financial 
circumstances and reliance on public transport mean that patients cannot always 
keep appointments (Harris, et al., 2011). Receiving treatment at some clinics 
requires the entire day, especially in large HIV clinics with long cues as these 
clinics serve thousands of patients.  This requires time off work and since all 
participants were assessed on the day they were at clinic for a check up may 
reflect renewed uncertainty about their medical results which are checked on that 
day. Stockouts of ART are also a reality in some clinics which means participants 
may not be sure that their medication will be available when they need it (Doctors 
Without Borders (MSF), 2016; the Rural Doctors Association of Southern Africa 
(RuDASA), 2016 and the Rural Health Advocacy Project (RHAP), 2016). 
Participants may experience more episodic fluctuations in their health challenges 
due to the socioeconomic and social circumstance in which they live. Coping with 
everyday activities in under resourced circumstances may be difficult in terms of 
accessing adequate nutrition, community support and employers that are 
understanding of time needed off work. (AIDS Foundation South Africa, 2016). 
This is an aspect of the HDQ that needs further investigation.    
5.4.4 Internal Consistency  
The internal consistency of the HDQ was compared to that established in other 
studies using the HDQ. The HDQ severity, episodic domains scale scores and 
total scores met pre-specified criteria for internal consistency reliability. This is a 
result similar to the previous study by O’Brien et al. (2015) in which they also 
determined the internal consistency reliability of the HDQ in developed countries 
(Canada and Ireland). The Cronbach’s alpha severity scores of the HDQ are 
better for the South African population than the Irish and Canadian population 
living with HIV as the scores only range between 0.92 to 0.93, while for Canadian 
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participants it ranges from 0.87 to 0.93 and 0.84 to 0.92 for Irish participants. The 
higher internal consistency Cronbach’s alpha scores for this study may reflect 
some duplication of content in the items with redundancy of items. These results 
may reflect the loading of items on different factors in the HDQ for this sample 
making some items redundant (Streiner, 2003).  
5.5 LIMITATIONS OF THE STUDY   
Only PLWHIV receiving ART were included in the study, and although this may 
have biased the sample as approximately only half of the PLWHIV in South Africa 
are accessing ART (Stats SA, 2015), it alleviated the necessity of establishing 
whether potential participants are living with HIV.  The reality is in a low resourced 
developing country like South Africa with a high prevalence of HIV. Not all 
PLWHIV will have access to ART but approximately half of the PLWHIV in South 
Africa are now accessing ART, reflecting an increase of nearly 2 million as 
compared to 2002. Due to changes in health policy, the number of individuals 
being provided with ART continues to rise yearly (Stats SA, 2015).    
Data on medical issues was difficult to obtain as medical information like WHO 
clinical staging and viral loads were missing in the case file.   
Research fatigue could have been a problem which resulted in patients at the 
clinic refusing to participate as they had already completed questionnaires in other 
studies. However, this did not affect the sample size nor does it affect the 
generalisability of the results as the participants represent the population of people 
living with HIV in Johannesburg and Soweto, South Africa. 
Assessment of the interpretability of the HDQ scores is important to understanding 
the meaning of the HDQ scores both for the health care providers and the patients 
as this will help to identify services, program and interventions that will reduce 
disabilities and increase overall wellness. 
The HDQ was initially developed for assessing disabilities in men living with HIV in 
urban areas and taking ART, living with concurrent health conditions and 
unemployment. In light of this, the HDQ in this study was with different known 
group variables in comparison to the Canadian samples as this study included 
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more women and employed participants, of whom the majority are not 
experiencing any concurrent health conditions and on ART. 
While this is the first HDQ validity study in a developing country, the transcultural 
validity of the HDQ is unknown and may affect the generalisability of this finding in 
other developing countries in that this limitation restricts our goals of generalizing 
these findings to South Africa. 
The study used a convenient sample and participants were not randomly selected. 
Findings from this study also under-represent young people living with HIV in 
South Africa. More so, people living with disabilities such as deafness, blindness, 
and psychiatric illness were under-represented in this study. These limitations 
therefore may affect the acceptability of these results as a true picture of validity of 
the HDQ and disabilities associated with HIV in this population. 
Despite these limitations, this study is an important step in statistically establishing 
the validity and reliability of the HDQ in developing countries. It also adds to the 
existing knowledge on the global impact of HIV on activity limitations, 
participations, restrictions and quality of life in relationships with social support in 
developing and low resource countries. Furthermore, this study has been able to 
reveal the importance of including uncertainty as a domain of disabilities in 
PLWHIV as this is the first study to explore HIV from episodic disability framework 
in a developing country, thereby revealing more areas where services, programs 
and interventions are needed to reduce disabilities and increase quality of life in 
PLWHIV. 
 5.6 METHODOLOGICAL STRENGTHS OF THE STUDY 
Rigour in terms of data collection and missing data were followed in this study as 
was the training of research assistants. The research assistants were familiar with 
all the assessment tools and were able to assist participants who they guided 
through the self-report questionnaires if necessary. This ensured that the 
participants understood the questions, increasing their ability to report on their 
impairments, activity limitations and participation restrictions which make up the 
construct of O’Brien et al (2014) as well as their QoL in the language of their 
choice (O’Brien et al 2014).  
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According to the COSMIN checklist the following were included in the study in 
relation to hypothesis testing, validity and reliability. 
The percentage of missing data was minimised by checking the questionnaires 
before the participants leave the research site. Two questionnaires were 
eliminated from the study because the participants have been on ART for less 
than 6 months and the other two were excluded because more than 10% of the 
items and/or domains were missing. 
The sample size was justified for survey sampling as well as factor analysis and 
convergent validity and the sample was larger than that calculated as necessary 
for the study. Hypotheses for convergent validity were determined based on priori 
factors from research by O’Brien et al (2014).  
The direction and magnitude of correlations was presented in the data analysis, 
and results with the reference assessment tools and their measurement properties 
as well as the convergent and divergent described in the literature review and 
methodology.  
The construct validity of the HDQ was assessed using factor analysis and was 
shown to consist of six factors, and measure of the construct of disability as 
described by O’Brien et al. (2014). The factor analysis indicated six factors for this 
study which showed discrepancies within the domains in the HDQ as described by 
O’Brien et al. (2014).  Items on the HDQ were appropriate for the age, gender and 
urban sample in this study and the assessment is specifically designed for 
PLWHIV (O’Brien et al., 2014). 
The criteria for internal consistency were met although the internal consistency for 
each domain was not calculated.  
5.7 CONCLUSION 
The demographics for the sample were shown to match others reported for 
PLWHIV in South Africa. The validity and reliability of the HDQ was determined for 
this sample which differed in terms of demographic factors and medical history 
from other samples of PLWHIV on which the HDQ had been validated. 
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The findings in the factor analysis indicate that the construct validity HDQ may be 
affected by these differences and support the importance of establishing validity of 
assessment tolls on different populations. 
For assessments to be valid they should provide scores that have the same 
meaning across different populations. They must be evaluated for differences in 
scoring and for factors that may differ from the original population on which the 
assessment was developed. While the language and self-report nature of the 
questionnaire was accommodated in this study to make the test accessible to 
participants by training research assistants to assist with administration of the test, 
other factors appear to have played a role in structure of the assessment which 
may affect interpretation and identification of disability in different domains on the 
HDQ. Thus before recommending the HDQ as a valid test for South African 
PLWHIV, particularly in light of 0 scores for some domains on the severity scale, 
further investigation into participants’ perceptions of the presence and severity of 
their disability as well as the episodic nature of their disability needs to be 
completed. 
The HDQ appears to measure the construct of disability in PLWHIV as defined by 
O’Brien et al. (2014) and shown in the confirmatory factor analysis and convergent 
and divergent correlation studies. The levels of disability assessed by the HDQ 
were also associated with known group factors in the South African sample 
indicating that the assessment is responsive to mils, moderate and severe 
disability levels (O’Brien et al., 2014). 
Based on the measurement of the construct of disability the internal consistency 
was established for the HDQ. The deficiency which may be related to the high 
Cronbach’s alpha scores for this aspect, however, may bring the relevance of all 
items into question.  
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CHAPTER 6: CONCLUSION  
6.1 CONCLUSION 
The aim of this study was to determine the validity of an assessment instrument, 
the HDQ for a sample of PLWHIV in South Africa. The HDQ had been researched 
in developed countries by O’Brien, et al. (2015) but not in South Africa and many 
other low resource countries where the presentation of HIV differs in a low 
resourced health system and economy (Stats SA, 2015).  The selection of a 
convenient sample of 498 participants in clinics in Johannesburg resulted in a 
sample that differed in gender, age, length of time on ART, the number of 
concurrent health conditions and employment rates from those used to test the 
validity of the HDQ previously. 
The HDQ validity was tested using factor analysis, convergent and divergent 
validity as well as whether known group hypotheses were supported by the levels 
of disability assessed in the South African sample.  
The principal component analysis results supported those found previously for the 
HDQ except for the domains related to activity limitations or difficulty with day to 
day activities where items loaded in the domain related to participation restrictions 
or challenges with social and community inclusion. Some items related to 
participation restrictions also loaded into the domain or uncertainty. These 
differences may have been related to the known group variables such as 
employment status and the number of concurrent health conditions that differ 
between this sample and that assessed by O’Brien et al. (2014) when she 
validated the HDQ in Canada (O’Brien et al., 2014). 
Confirmatory factor analysis in this study indicated an acceptable goodness of fit 
for the framework used for identifying the construct of disability in the South 
African sample. The maximum likelihood ratio also confirmed that the factors 
loaded on one construct – that of disability. Therefore, the HDQ can be accepted 
as a tool which measures disability in PLWHIV in the South African sample. This 
was confirmed by the convergence to scores on a reference assessment 
instrument which assesses activity limitations and participation restrictions, the 
WHODAS 2.  Divergent validity from assessment MOS-SSS indicated that the 
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HDQ assessed disability and not social support. It can therefore be accepted that 
the HDQ is a valid assessment instrument for the overall evaluation of disability 
according to the Episodic Framework developed by O’Brien et al. (2008) in 
PLWHIV in South Africa.   
The HDQ was also found to be assessing different levels of disability when these 
were compared to known group variables related to HIV. Although there were 
more female participants in this study, this did not affect the level of disability. 
Other known factors such as the number of concurrent health conditions and 
shorter time on ART was congruent with the lower presence and severity of 
disability found in the South African sample.  The level of severity and presence of 
disability was also significantly different in PLWHIV who were employed and 
unemployed, confirming the validity of the test to identify higher levels of disability 
in those who are no longer able to work. 
When the domains and episodic nature of disability were considered some 
differences were found between those reported previously in the HDQ in 
developed countries and those found for the sample of PLWHIV in South Africa. 
The principal component factor loading structure of the HDQ was found to fit the 
six domains of the HDQ with the exception of Domain 5; difficulties with day to day 
activities which loaded with Domain 6 Challenges in social inclusion. These two 
domains can be considered to assess occupational performance related to 
participation restrictions and this finding may reflect those found for the episodic 
nature of disability. 
These findings may be related to the effects of living in low resourced 
circumstances where participants encounter difficulties in accessing health care 
and coping with a chronic illness may be affected by socioeconomic or social 
circumstances. The validity of the HDQ in assessing participation restrictions in a 
low resourced country as well as the added burden placed on those living with HIV 
in a developing country such as South Africa needs further investigation. 
The research study did consider the validity of the first HIV specific disability 
instrument for use in South Africa. In addition, the study contributed to the known 
literature related to the socio-demographic profile of those individuals and also the 
effect of this profile on disability in those living with HIV in Gauteng Province. 
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6.1 RECOMMENDATIONS 
The research project highlighted several areas where research is still needed, 
particularly in relation to mental and emotional symptoms, participation restrictions 
as well as the episodic nature of disability in PLWHIV. This study reported a higher 
occurrence of episodic disability in PLWHIV in South Africa when compared with 
other studies in Canada and Ireland, more studies are needed to confirm this 
observation. 
The current research participants could be followed up longitudinally for a longer 
period to determine the validity of the HDQ in identifying the change in disability in 
PLWHIV over time in one context.  
It is recommended that all South Africa clinics computerise the medical records to 
minimise missing medical information. 
The length of the HDQ was one of the reasons why some participants did not 
participate as they complained it is extended and would take a lot of their time. 
Further revision of this instrument may include a short-form version to encourage 
patient participation in future studies and enhance intended feasibility of the HDQ 
in clinical settings. 
Changes in disabilities over time and effectiveness of interventions, especially in 
low resource and HIV endemic countries, needs to be examined by exploring 
additional psychometric assessment of responsiveness of the HDQ as this study 
involves participants at one time only. 
6.2.1 Clinical Recommendations 
Patients attending HIV clinics should be routinely assessed for disability. The 
assessments used in this study were all self-report assessments which the 
patients needed assistance to complete. Therefore, if an assessment such as the 
HDQ is used it will probably have to be with assistance from a therapist or therapy 
technician.  
Those identified with mild disability should be included in preventive programmes 
so as to be maintained at this level. The patients with moderate to extreme 
disability should receive appropriate rehabilitation to assist with maintenance of 
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independence and resolution of impairments and participation restrictions if 
possible. 
In conclusion, it appears that the HDQ is an appropriate assessment to determine 
disability in PLWHIV in South Africa as this presents the best option currently for 
the assessment of disability related to impairments, activity limitations and 
participation restrictions for this population which should be assessed by 
rehabilitation services.  
There are some reservations about the validity and reliability of the HDQ for this 
sample and therefore it is recommended that further analysis of the HDQ results of 
this study are completed using Rasch analysis before the HDQ is used in the 
clinical setting in South Africa due to some discrepancies in the factor analysis 
found for this study. Convergence of the HDQ results could also be made with 
assessment tools that measure occupational performance in activities, and 
participation such as the Activity Participation Outcome Measure (APOM) by 
Casteleijn and Graham, (2012) to confirm the results on the self-report of 
disability.   
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APPENDIX A DEMOGRAPHIC QUESTIONNAIRE 
Please answer these questions by marking one line.  
1. Gender: _____ 0) Male _____ 1) Female  
2. Years of age: _____  
3. In which group do you mostly place yourself?  
_____ 1) Black   _____ 4) Caucasian/White  
_____ 2) Coloured   _____ 5) Indian  
_____ 3) Asian _____   6) Other _________________  
4. What is your CD4 count level______________________________________?  
5. What is your current marital status?  
_____ 1) Single (never married) _____ 4) Widowed  
_____ 2) Married                           _____ 5) Divorced  
_____ 3) In committed relationship _____ 6) Separated  
______7) Complicated 
6. Do you have any children? _____ 0) No _____ 1) Yes (including step or 
adopted)  
7. How many children? _____  
8. How far did you go in school?  
_____ 1) Less than Grade 10                _____ 5) Bachelor’s degree  
_____ 2) Completed Grade 10               _____ 6) Master’s degree  
_____ 3) Matric                       _____ 7) Ph.D.,  .  
_____ 4) Some tertiary qualification        _____ 8) Other _________________  
 
9. Current employment:  
_____ 1) Employed full time or more _____ 4) In school full time  
_____ 2) Employed part-time _____ 5) Homemaker _____ 6) Unemployed  
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_____ 3) Self-employed _____ 7) Retired or disabled    
10 Are you currently receiving a disability grant ___________- 
11. How long have you been on antiretroviral treatments___________________? 
12. Please list any current medical problem(s) that you have: 
________________________________________________________ 
  
111 
 
APPENDIX B  HIV DISABILITY QUESTIONNAIRE 
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APPENDIX C  WORLD HEALTH ORGANISATION DISABILITY 
ASSESSMENT SCALE (WHODAS-2) 
 
In the past 30 days, how much difficulty did you have in: 
Understanding and communicating 
D1.1 Concentrating on 
doing something 
for ten minutes? 
None Mild Moderate Severe Extreme or 
cannot do 
D1.2 Remembering to 
do important 
things? 
None Mild Moderate Severe Extreme or 
cannot do 
D1.3 Analysing and 
finding solutions to 
Problems in day-
to-day life? 
None Mild Moderate Severe Extreme or 
cannot do 
D1.4 Learning a new 
task, for example, 
learning how to get 
to a new place? 
None Mild Moderate Severe Extreme or 
cannot do 
D1.5 Generally 
understanding 
what people say? 
None Mild Moderate Severe Extreme or 
cannot do 
D1.6 Starting and 
maintaining a 
conversation? 
None Mild Moderate Severe Extreme or 
cannot do 
Getting around 
D2.1 Standing for long 
periods such as 30 
minutes? 
None Mild Moderate Severe Extreme or 
cannot do 
D2.2 Standing up from 
sitting down? 
None Mild Moderate Severe Extreme or 
cannot do 
D2.3 Moving around 
inside your home? 
None Mild Moderate Severe Extreme or 
cannot do 
D2.4 Getting out of your 
home? 
None Mild Moderate Severe Extreme or 
cannot do 
D2.5 Walking a long 
distance such as a 
kilometre[or 
equivalent]? 
None Mild Moderate Severe Extreme or 
cannot do 
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In the past 30 days, how much difficulty did you have in: 
Self-care 
D3.1 Washing your 
whole body? 
None Mild Moderate Severe Extreme or 
cannot do 
D3.2 Getting dressed? None Mild Moderate Severe Extreme or 
cannot do 
D3.3 Eating? None Mild Moderate Severe Extreme or 
cannot do 
D3.4 Staying by yourself 
for a few days? 
None Mild Moderate Severe Extreme or 
cannot do 
Getting along with people 
D4.1 Dealing with people 
you do not know? 
None Mild Moderate Severe Extreme or 
cannot do 
D4.2 Maintaining a 
friendship? 
None Mild Moderate Severe Extreme or 
cannot do 
D4.3 Getting along with 
people who are 
close to you? 
None Mild Moderate Severe Extreme or 
cannot do 
D4.4 Making new 
friends? 
None Mild Moderate Severe Extreme or 
cannot do 
D4.5 Sexual activities? None Mild Moderate Severe Extreme or 
cannot do 
Life activities 
D5.1 Taking care of your 
household 
Responsibilities? 
None Mild Moderate Severe Extreme or 
cannot do 
D5.2 Doing most 
important 
household tasks 
well? 
None Mild Moderate Severe Extreme or 
cannot do 
D5.3 Getting all the 
household work 
done that you 
needed to do? 
None Mild Moderate Severe Extreme or 
cannot do 
D5.4 Getting your 
household work 
done as quickly as 
needed? 
None Mild Moderate Severe Extreme or 
cannot do 
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If you work (paid, non-paid, self-employed) or go to school, complete questions 
D5.5 -D5.8, below. Otherwise, skip to D6.1. 
Because of your health condition, in the past 30 days, how much difficulty did you 
have in: 
D5.5 Your day-to-day 
work/school? 
None Mild Moderate Severe Extreme or 
cannot do 
D5.6 Doing your most 
important 
work/school tasks 
well? 
None Mild Moderate Severe Extreme or 
cannot do 
D5.7 Getting all the 
work done that 
you need to do? 
None Mild Moderate Severe Extreme or 
cannot do 
D5.8 Getting your work 
done as quickly as 
needed? 
None Mild Moderate Severe Extreme or 
cannot do 
 
Participation in society 
In the past 30 days: 
D6.1 How much of a 
problem did you 
have in joining in 
community 
activities (for 
example, 
festivities, religious 
or other activities) 
in the same way as 
anyone else can? 
None Mild Moderate Severe Extreme or 
cannot do 
D6.2 How much of a 
problem did you 
have because of 
barriers or 
hindrances in the 
world around you? 
None Mild Moderate Severe Extreme or 
cannot do 
D6.3 How much of a 
problem did you 
have living with 
dignity because of 
the attitudes and 
actions of others? 
None Mild Moderate Severe Extreme or 
cannot do 
D6.4 How much time did 
you spend on your 
health condition, or 
None Mild Moderate Severe Extreme or 
cannot do 
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its consequences? 
D6.5 How much have 
you been 
emotionally 
affected by your 
health condition? 
None Mild Moderate Severe Extreme or 
cannot do 
D6.6 How much has 
your health been a 
drain on the 
financial resources 
of you or your 
family? 
None Mild Moderate Severe Extreme or 
cannot do 
D6.7 How much of a 
problem did your 
family have 
because of your 
health problems? 
None Mild Moderate Severe Extreme or 
cannot do 
D6.8 How much of a 
problem did you 
have in doing 
things by yourself 
for relaxation or 
Pleasure? 
None Mild Moderate Severe Extreme or 
cannot do 
 
 
 
 Overall, in the past 30 days, how 
many days were these 
difficulties present? 
 
Record number of days ____ 
 In the past 30 days, for how many 
days were you totally 
unable to carry out your usual 
activities or work because of 
any health condition? 
 
Record number of days ____ 
 In the past 30 days, not counting the 
days that you were 
totally unable, for how many days 
did you cut back or reduce 
your usual activities or work because 
of any health condition? 
 
Record number of days ____ 
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APPENDIX D  MEDICAL OUTCOMES STUDY SOCIAL SUPPORT 
SURVEY (MOS-SSS) 
 
1.0 About how many close friends and close relatives do you have (people you 
feel at ease with and can talk to about what is on your mind)? 
       Write in number of close friends and 
        close relatives:  
 
People sometimes look to others for companionship, assistance, or other 
types of support. How often is each of the following kinds of support available 
to YOU if you need it? 
      (Circle One Number on Each Line) 
                 None      A Little    Some       Most      All 
                 Of the     of the      of the       of the    of 
the 
                 Time       Time       Time        Time       
Time 
2.0 Someone to help you if you were 
confined to bed          
1 2 3 4 5 
3.0 Someone you can count on to listen to 
you when you need to talk 
1 2 3 4               5 
4.0 Someone to give you good advice about 
a crisis 
1 2 3 4 5 
5.0 Someone to take you to the doctor if you 
needed it             
1 2 3 4 5 
6.0 Someone who shows you love and 
affection                       
1 2 3 4 5 
7.0 Someone to have a good time with                      
                 
1 2 3 4 5 
8.0 Someone to give you information to help 
you understand a situation 
1 2 3 4 5 
9.0 Someone to confide in or talk to about 
yourself or            your problems  
1 2 3 4 5 
10 Someone who hugs you                                                     1 2 3 4 5 
11 Someone to get together with for 
relaxation 
 
1 2 3 4 5 
12 Someone to prepare your meals if you 
were unable to do it yourself 
1 2 3 4 5 
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13 Someone whose advice you really want         
                     
1 2 3 4 5 
14 Someone to do things with to help you 
get your mind 
off things  
1 2 3 4 5 
15 Someone to help with daily chores if you 
were sick 
            
1 2 3 4 5 
16 Someone to share your most private 
worries and fears                                            
with 
1 2 3 4 5 
17 Someone to turn to for suggestions about 
how to deal                                      with a 
personal problem 
1 2 3 4 5 
18 Someone to do something enjoyable with               
             
1 2 3 4 5 
19 Someone who understands your 
problems         
                 
1 2 3 4 5 
20 Someone to love and make you feel 
wanted 
1 2 3 4 5 
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APPENDIX F ACCESS LETTER REQUESTING PERMISSION TO 
CONDUCT RESEARCH 
 
www.wits.ac.za 
 
23.5.2016 
 
To Whom it May Concern, 
…….. 
Dear Sir/Ma. 
REQUEST FOR PERMISSION TO CONDUCT RESEARCH 
 Study title: VALIDITY OF THE HIV DISABILITY QUESTIONNAIRE FOR 
PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS IN SOUTH AFRICA 
 
I, Adetunji Abiodun Adeleke am a registered Master’s student in the Department of 
occupational therapy at the University of Witwatersrand. My supervisor is Mrs. 
Denise Franzsen and my associate supervisor is Mrs. Rulaine Smith 
The proposed topic of my research is activity limitations, participation restrictions 
and quality of life in patients with human immunodeficiency virus. The objectives of 
the study are: 
a. Determine the content validity and convergent validity of the HDQ with the 
World Health Organisation Disability Assessment Scale (WHODAS-2) and 
the divergent validity with the Medical Outcomes Study Social Support 
Survey (MOS-SSS) on a sample of persons with HIV living in 
Johannesburg. 
b. To determine the reliability in terms of internal consistency of the HDQ on 
the South African sample. 
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c. Determine the activity limitations, performance restrictions and quality of life 
on a sample of persons with HIV living in Johannesburg using the HDQ.  
d. Determine the relationship between the level of activity limitations, 
performance restrictions, and quality of life of PLWHIV. 
e. Investigate the effects of operating variables (demographic and medical 
factors) on the activity limitations, participation restrictions and quality of life 
in comparison to results published in Canadian and Irish studies using the 
HDQ.   
The research would involve people living with HIV filling in three self administered 
questionnaires once off. This can be done at the clinic while they are waiting for 
treatment.. An assistant will be available to assist them if they need help 
understanding the questions. All questions will concern the activities they do on a 
daily basis as well as some basic demographic and medical information. The 
patients’ names will not be recorded on any forms. 
I am hereby seeking your consent to allow me to use your clinic for this study. To 
assist you in reaching a decision, I have attached to this letter: 
A copy of an ethical clearance certificate issued by the University 
(a) A copy the research protocol which I intend using in my research 
Should you require any further information, please do not hesitate to contact me or 
my supervisor. Our contact details are as follows: 
1. Adeleke Adetunji Abiodun 
Tel. 0848869572 email. a.adetunji12@hotmail.com 
1. Mrs. Denise Franzsen or Mrs. Rulaine Smith 
Wits OT Dept, 7 York Rd., Parktown 2193,Email. denise.franzsen@wits ac.za. 
Tel.0117173701 
Your permission to conduct this study will be greatly appreciated. If you agree 
please sign the attached permission form. 
Yours sincerely, 
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PERMISSION TO CONDUCT RESEARCH  
 
 I _______________  the manager of the                             Clinic give permission 
for the study entitled : ACTIVITY LIMITATIONS, PARTICIPATION 
RESTRICTIONS AND QUALITY OF LIFE IN PATIENTS WITH HUMAN 
IMMUNODEFICIENCY VIRUS to be conducted in this clinic. 
 
 
Signature ____________________________ 
Name __________________________ 
Date _________________________ 
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APPENDIX G  INFORMATION DOCUMENT FOR PARTICIPANTS 
 
Study title: VALIDITY OF THE HIV DISABILITY QUESTIONNAIRE FOR 
PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS IN SOUTH AFRICA 
\ 
 
Good day  
Introduction: 
I, Mr. Adetunji Abiodun, Adeleke a master’s student at the University of the 
Witwatersrand, am doing a research on activity limitations, participation 
restrictions and quality of life in people living with HIV in Johannesburg.  
In this study we want to learn more about the challenges you face in your daily 
activities with the use of questionnaires. This is a study involving research (one-
time assessment with the questionnaires) this not routine care and this is been 
done to reduce the level of disability in this society and validate the HIV disability 
questionnaire (HDQ).  
Invitation to participate:  We are inviting you to take part in a research study that 
aims to check if  the HDQ can be used with people in South Africa and help to 
provide answers to assist in reducing disability among people living with HIV. 
What is involved in the study – You will be required to complete answers on 
questionnaires about your daily activities and any problems you have doing these 
at one time only.  Your involvement in this research will include filling in the 
questionnaires with help of an assistant if you need it while at the clinic. The 
questionnaires will include some personal information but will be anonymous as 
your name will not be required on any form. The other questions which will take 25 
to 30 minutes to complete will have questions about every day activities at home, 
work and social activities. Some of the questions that would be asked also 
includes aspects of mobility, self care, how much support do you receive from 
people when needed. One of the questions is about your CD4 count. Please sign 
permission to obtain this information from your file. 
Please let me know if you need assistance with translating the questions of filling 
them in. There is someone helping me that can translate questions into the 
language you are familiar with and assist you. If you need help a quite private 
place will be organised so you are not overheard but it may take longer, up to 40 
minutes to complete the questionnaire.  
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Risks of being involved in the study. There are no risks in being involved in the 
study And no direct benefits to you. It is hoped that the study will assist in setting 
up appropriate services for people living with HIV. If you feel distressed by some 
of the questions and wish to discuss this with someone you will be provided with 
the contact details of a psychologist or occupational therapists you can contact if 
you wish to follow up on this. 
Participation is voluntary, and if you don’t want to take part this will not affect 
your treatment in any way. You can also stop taking part at any time without any 
consequence or penalty loss of benefits to which you are otherwise entitled. 
Confidentiality: Efforts will be made to keep personal information confidential and 
no material that can identify you personally will be used in the research.  All 
records will be destroyed after six years according to HPCSA regulations or after 
the study is published.  
 Organizations that may inspect and/or copy this research records for quality 
assurance and data analysis include groups such as the Research Ethics 
Committee. 
Feedback from the study will be available on request. 
Contact details of researcher. 
2. Adeleke Adetunji Abiodun 
Tel. 0848869572 email. a.adetunji12@hotmail.com  
Supervisors  
3. Mrs. Denise Franzsen 
 Wits OT Dept, 7 York Rd., Parktown 2193, Email. denise.franzsen@wits ac.za. 
Tel.0117173701 
4. Mrs. Rulaine Smith 
Wits OT Dept, 7 York Rd., Parktown 2193, Email. rulaine.smith@wits.ac.za. Tel. 
0117173701 
Contact details of HREC administrator and chair – for reporting of complaints / 
problems. Please contact  
Chairperson of the ethics committee Prof P Cleaton-Jones at Zanele 
Ndlovu@wits.ac.za or 011-717-1234   
If you agree to take part please sign the consent form on the next page   
Regards  
  
135 
 
APPENDIX H  INFORMED CONSENT FORM 
 
I ______________________________- have read, or have had explained to me 
in my first language the participant information sheet and i understand the 
participant information sheet.   
I understand that taking part in this study is voluntary (my choice) and that I may 
withdraw from the study at any time without this affecting my medical care. I 
understand that my participation in this study is confidential and that no material, 
which could identify me personally, will be used in any reports on this study. 
I agree to take part in the study 
 
Participant’s name: 
Signature: Date: 
 
Declaration by member of research team: 
I have given a verbal explanation of the research project to the participant, and 
have answered the participant’s questions about it.   
 
I believe that the participant understands the study and has given informed 
consent to participate. 
 
Researcher’s name: 
Signature: Date: 
 
 
  
If you need an INTERPRETER, please tell us. 
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PERMISSION TO ACCESS FILE  
 
I ______________________________- agrre that the researcher may access my 
CD4 count from my file. 
 
Participant’s name: 
Signature: Date: 
 
  
If you need an INTERPRETER, please tell us. 
 
137 
 
APPENDIX I FACTOR ANALYSIS 
FACTOR ANALYSIS PATTEN MATRIX - HIV DISABILITY 
QUESTIONNAIRE  SEVERITY SCALE 
 Pattern Matrixa 
   Factor Loadings (Varimax normalized) (HDQ severity) 
 Variable Extraction: Principal components 
   (Marked loadings are >.300000) 
   Factor Factor Factor Factor Factor Factor 
   1 2 4 4 5 6 
Physical 
Domain 
(1) 
HDQ1 0.44      
HDQ2 0.33      
HDQ3 0.58      
HDQ4 0.57      
HDQ5 0.37      
HDQ6 0.36      
HDQ7 0.58      
HDQ8 0.37      
HDQ9 0.37      
HDQ10 0.37      
HDQ11 0.62      
HDQ12 0.58      
HDQ13 0.65      
HDQ14 0.56      
HDQ15 0.34      
HDQ16 0.51      
HDQ17 0.39      
HDQ18 0.45      
HDQ19 0.13      
HDQ20 0.51      
Cognitive 
Domain 
(2) 
HDQ21  0.44  
 
  
HDQ22  0.55  
 
  
HDQ23  0.56  
 
  
Mental and 
Emotional 
Domain 
(3) 
HDQ24   0.38    
HDQ25   0.49    
HDQ26   0.39    
HDQ27   0.63    
HDQ28   0.36    
HDQ29   0.77    
HDQ30   0.76    
HDQ31   0.68    
HDQ32   0.64    
HDQ33   0.64    
HDQ34   0.61    
Uncertainty 
(4) 
HDQ35    0.64   
HDQ36    0.55   
HDQ37    0.73   
HDQ38    0.72   
HDQ39    0.69   
HDQ40    0.65   
HDQ41    0.65   
HDQ42    0.48   
HDQ43    0.63   
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HDQ44 
   0.53  
 
HDQ45    0.67   
HDQ46    0.68   
HDQ47    0.58   
HDQ48    0.33   
Difficulties 
with day to 
day 
activities  
(5) 
HDQ49     0.65  
HDQ50     0.74  
HDQ51     0.70  
HDQ52     0.11 0.74 
HDQ53     0.17 0.73 
HDQ54     0.22 0.68 
HDQ55     0.14 0.72 
HDQ56     0.10 0.43 
HDQ57     0.18 0.74 
Challenges 
to Taking 
Part in 
Social and 
Community 
Life (6) 
HDQ58      0.53 
HDQ59      0.53 
HDQ60      0.43 
HDQ61      0.62 
HDQ62      0.57 
HDQ63      0.53 
HDQ64    0.57  0.27 
HDQ65      0.33 
HDQ66      0.35 
HDQ67    0.52  0.12 
HDQ68    0.36  0.27 
HDQ69      0.45 
 Expl.Var 6.24 Factor 6.79 Factor 3.29 0.27 
 
MAXIMUM LIKELIHOOD FACTORS 
 
Variable 
Factor Loadings (Unrotated) (HDQ severity) 
Extraction: Maximum likelihood factors 
(Marked loadings are >.300000) 
Factor 
1 
Factor 
2 
Factor 
3 
Factor 
4 
Factor 
5 
Factor 
6 
HDQ1 -0.44 -0.12 -0.10 0.20 -0.14 0.01 
HDQ2 -0.25 0.01 0.05 0.15 -0.20 -0.04 
HDQ3 -0.44 -0.15 -0.03 0.24 -0.27 0.01 
HDQ4 -0.45 -0.13 -0.20 0.25 -0.19 0.09 
HDQ5 -0.41 -0.20 -0.23 0.12 -0.02 0.18 
HDQ6 -0.42 -0.21 -0.34 0.13 -0.06 0.10 
HDQ7 -0.54 -0.27 -0.13 0.22 -0.14 0.16 
HDQ8 -0.25 -0.17 0.04 0.10 -0.17 0.02 
HDQ9 -0.35 -0.02 -0.14 0.12 -0.15 0.08 
HDQ10 -0.43 -0.23 -0.07 0.13 -0.14 -0.05 
HDQ11 -0.45 -0.14 -0.06 0.28 -0.23 0.12 
HDQ12 -0.63 -0.19 -0.08 0.26 -0.14 0.10 
HDQ13 -0.47 -0.18 -0.17 0.26 -0.22 0.27 
HDQ14 -0.38 -0.11 -0.10 0.24 -0.22 0.08 
HDQ15 -0.38 0.07 0.00 0.26 -0.04 -0.04 
HDQ16 -0.30 -0.06 0.05 0.28 -0.24 -0.01 
HDQ17 -0.51 -0.02 -0.08 0.20 -0.06 0.04 
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Variable 
Factor Loadings (Unrotated) (HDQ severity) 
Extraction: Maximum likelihood factors 
(Marked loadings are >.300000) 
Factor 
1 
Factor 
2 
Factor 
3 
Factor 
4 
Factor 
5 
Factor 
6 
HDQ18 -0.32 -0.10 -0.15 0.28 -0.15 0.12 
HDQ19 -0.17 -0.02 -0.09 0.12 -0.04 -0.02 
HDQ20 -0.54 -0.18 -0.03 0.17 -0.14 0.09 
HDQ21 -0.44 -0.12 -0.10 0.20 -0.14 0.01 
HDQ22 -0.25 0.01 0.05 0.15 -0.20 -0.04 
HDQ23 -0.44 -0.15 -0.03 0.24 -0.27 0.01 
HDQ24 -0.45 -0.13 -0.20 0.25 -0.19 0.09 
HDQ25 -0.41 -0.20 -0.23 0.12 -0.02 0.18 
HDQ26 -0.42 -0.21 -0.34 0.13 -0.06 0.10 
HDQ27 -0.54 -0.27 -0.13 0.22 -0.14 0.16 
HDQ28 -0.25 -0.17 0.04 0.10 -0.17 0.02 
HDQ29 -0.35 -0.02 -0.14 0.12 -0.15 0.08 
HDQ30 -0.43 -0.23 -0.07 0.13 -0.14 -0.05 
HDQ31 -0.45 -0.14 -0.06 0.28 -0.23 0.12 
HDQ32 -0.63 -0.19 -0.08 0.26 -0.14 0.10 
HDQ33 -0.47 -0.18 -0.17 0.26 -0.22 0.27 
HDQ34 -0.38 -0.11 -0.10 0.24 -0.22 0.08 
HDQ35 -0.38 0.07 0.00 0.26 -0.04 -0.04 
HDQ36 -0.30 -0.06 0.05 0.28 -0.24 -0.01 
HDQ37 -0.51 -0.02 -0.08 0.20 -0.06 0.04 
HDQ38 -0.32 -0.10 -0.15 0.28 -0.15 0.12 
HDQ39 -0.17 -0.02 -0.09 0.12 -0.04 -0.02 
HDQ40 -0.54 -0.18 -0.03 0.17 -0.14 0.09 
HDQ41 -0.39 -0.13 -0.09 0.22 -0.16 -0.06 
HDQ42 -0.51 -0.08 -0.03 0.33 -0.13 -0.14 
HDQ43 -0.45 -0.12 -0.12 0.26 -0.04 -0.17 
HDQ44 -0.47 0.03 -0.13 0.17 0.09 -0.01 
HDQ45 -0.65 0.12 -0.04 0.22 0.01 -0.02 
HDQ46 -0.69 0.20 -0.14 0.09 -0.02 -0.05 
HDQ47 -0.63 0.18 0.20 0.10 0.17 -0.03 
HDQ48 -0.50 -0.06 -0.02 0.03 0.09 0.10 
HDQ49 -0.71 0.13 0.21 0.17 0.36 0.03 
HDQ50 -0.67 0.12 0.24 0.17 0.33 0.02 
HDQ51 -0.65 0.15 0.05 0.12 0.31 0.03 
HDQ52 -0.70 0.19 0.04 0.24 0.16 -0.08 
HDQ53 -0.75 0.24 0.05 0.16 0.17 -0.13 
HDQ54 -0.61 0.15 0.10 0.22 0.18 -0.06 
HDQ55 -0.72 0.35 -0.12 -0.03 -0.01 -0.09 
HDQ56 -0.63 0.26 -0.16 -0.01 -0.02 -0.14 
HDQ57 -0.67 0.25 -0.34 -0.26 -0.05 -0.18 
HDQ58 -0.64 0.21 -0.35 -0.29 -0.09 -0.22 
HDQ59 -0.67 0.24 -0.20 -0.16 -0.10 -0.03 
HDQ60 -0.61 0.24 -0.19 -0.05 -0.11 -0.13 
HDQ61 -0.58 0.24 -0.24 -0.12 -0.06 -0.12 
HDQ62 -0.49 0.12 -0.10 -0.13 0.08 -0.14 
HDQ63 -0.63 0.26 -0.12 -0.14 0.00 0.01 
HDQ64 -0.68 0.10 -0.06 -0.15 0.03 0.10 
HDQ65 -0.54 0.43 0.00 -0.17 -0.03 0.28 
HDQ66 -0.54 0.41 -0.01 -0.21 -0.06 0.33 
HDQ67 -0.35 0.26 -0.22 -0.18 0.03 0.02 
HDQ68 -0.56 0.03 0.18 -0.01 -0.11 -0.12 
HDQ69 -0.49 -0.42 -0.30 -0.11 0.13 0.04 
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Eigenvalues for HIV Disability Questionnaire 
 
Value 
Eigenvalues (HDQ severity) 
Extraction: Principal components 
Eigenvalue % Total 
variance 
Cumulative 
Eigenvalue 
Cumulative 
% 
1 20.90982 30.30408 20.90982 30.30408 
2 4.54613 6.58860 25.45595 36.89268 
3 3.06093 4.43614 28.51688 41.32882 
4 2.30469 3.34014 30.82158 44.66895 
5 1.91226 2.77139 32.73384 47.44035 
6 1.64144 2.37889 34.37528 49.81924 
 
 
